{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:27:00Z","timestamp":1793726820263,"version":"4.6.1"},"reference-count":246,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:00:00Z","timestamp":1745798400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:00:00Z","timestamp":1745798400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["BT\/RLF\/Re\u2010entry\/45\/2014"],"award-info":[{"award-number":["BT\/RLF\/Re\u2010entry\/45\/2014"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009053","name":"Wellcome Trust DBT India Alliance","doi-asserted-by":"publisher","award":["IA\/S\/22\/2\/506517"],"award-info":[{"award-number":["IA\/S\/22\/2\/506517"]}],"id":[{"id":"10.13039\/501100009053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mamm Genome"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s00335-025-10128-w","type":"journal-article","created":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T14:52:50Z","timestamp":1745851970000},"page":"444-464","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Alpha-synuclein pathology and Parkinson\u2019s disease-related olfactory dysfunctions: an update on preclinical models and therapeutic approaches"],"prefix":"10.1007","volume":"36","author":[{"given":"Jancy Nixon","family":"Abraham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devesh","family":"Rawat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyadharshini","family":"Srikanth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisni P.","family":"Sunny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nixon M.","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,28]]},"reference":[{"key":"10128_CR1","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.15252\/embj.201593411","volume":"35","author":"S Abounit","year":"2016","unstructured":"Abounit S, Bousset L, Loria F, Zhu S, de Chaumont F, Pieri L, Olivo-Marin JC, Melki R, Zurzolo C (2016) Tunneling nanotubes spread fibrillar alpha-synuclein by intercellular trafficking of lysosomes. EMBO J 35:2120\u20132138","journal-title":"EMBO J"},{"key":"10128_CR2","unstructured":"Abraham NM (2023) Olfactory-action meter for precise quantification of olfactory dysfunctions and neurocognitive deficits. US Patent 11786164"},{"key":"10128_CR4","first-page":"865","volume":"44","author":"NM Abraham","year":"2004","unstructured":"Abraham NM, Spors H, Carleton A, Margrie TW, Kuner T, Schaefer AT (2004) Maintaining accuracy at the expense of speed: stimulus similarity defines odor discrimination time in mice. Neuron 44:865\u2013876","journal-title":"Neuron"},{"key":"10128_CR3","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.neuron.2010.01.009","volume":"65","author":"NM Abraham","year":"2010","unstructured":"Abraham NM, Egger V, Shimshek DR, Renden R, Fukunaga I, Sprengel R, Seeburg PH, Klugmann M, Margrie TW, Schaefer AT, Kuner T (2010) Synaptic Inhibition in the olfactory bulb accelerates odor discrimination in mice. Neuron 65:399\u2013411","journal-title":"Neuron"},{"key":"10128_CR5","doi-asserted-by":"crossref","unstructured":"Abraham NM, Vincis R, Lagier S, Rodriguez I, Carleton A (2014) Long term functional plasticity of sensory inputs mediated by olfactory learning. Elife 3, e02109","DOI":"10.7554\/eLife.02109"},{"key":"10128_CR6","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1128\/MMBR.67.4.657-685.2003","volume":"67","author":"N Agrawal","year":"2003","unstructured":"Agrawal N, Dasaradhi PV, Mohmmed A, Malhotra P, Bhatnagar RK, Mukherjee SK (2003) RNA interference: biology, mechanism, and applications. Microbiol Mol Biol Rev 67:657\u2013685","journal-title":"Microbiol Mol Biol Rev"},{"key":"10128_CR7","doi-asserted-by":"publisher","first-page":"5233","DOI":"10.1039\/D2NA00524G","volume":"4","author":"OAA Alabrahim","year":"2022","unstructured":"Alabrahim OAA, Azzazy HME (2022) Polymeric nanoparticles for dopamine and levodopa replacement in Parkinson\u2019s disease. Nanoscale Adv 4:5233\u20135244","journal-title":"Nanoscale Adv"},{"key":"10128_CR8","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.neulet.2018.12.011","volume":"696","author":"R Alizadeh","year":"2019","unstructured":"Alizadeh R, Kamrava SK, Bagher Z, Farhadi M, Falah M, Moradi F, Boroujeni ME, Soleimani M, Kamyab A, Komeili A (2019) Human olfactory stem cells: as a promising source of dopaminergic neuron-like cells for treatment of Parkinson\u2019s disease. Neurosci Lett 696:52\u201359","journal-title":"Neurosci Lett"},{"key":"10128_CR9","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1002\/mds.25421","volume":"28","author":"S Appel-Cresswell","year":"2013","unstructured":"Appel-Cresswell S, Vilarino-Guell C, Encarnacion M, Sherman H, Yu I, Shah B, Weir D, Thompson C, Szu-Tu C, Trinh J, Aasly JO, Rajput A, Rajput AH, Jon Stoessl A, Farrer MJ (2013) Alpha-synuclein p.H50Q, a novel pathogenic mutation for Parkinson\u2019s disease. Mov Disord 28:811\u2013813","journal-title":"Mov Disord"},{"key":"10128_CR10","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.brs.2022.05.005","volume":"15","author":"BW Badran","year":"2022","unstructured":"Badran BW, Gruber EM, O\u2019Leary GH, Austelle CW, Huffman SM, Kahn AT, McTeague LM, Uhde TW, Cortese BM (2022) Electrical stimulation of the trigeminal nerve improves olfaction in healthy individuals: A randomized, double-blind, sham-controlled trial. Brain Stimul 15:761\u2013768","journal-title":"Brain Stimul"},{"key":"10128_CR11","doi-asserted-by":"publisher","first-page":"100163","DOI":"10.1016\/j.dscb.2024.100163","volume":"16","author":"D Baggett","year":"2024","unstructured":"Baggett D, Olson A, Parmar MS (2024) Novel approaches targeting \u03b1-Synuclein for Parkinson\u2019s disease: current progress and future directions for the disease-modifying therapies. Brain Disorders 16:100163","journal-title":"Brain Disorders"},{"key":"10128_CR12","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1146\/annurev-neuro-080317-062048","volume":"41","author":"CN Bedbrook","year":"2018","unstructured":"Bedbrook CN, Deverman BE, Gradinaru V (2018) Viral strategies for targeting the central and peripheral nervous systems. Annu Rev Neurosci 41:323\u2013348","journal-title":"Annu Rev Neurosci"},{"key":"10128_CR13","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1212\/WNL.0000000000200878","volume":"99","author":"G Bellomo","year":"2022","unstructured":"Bellomo G, De Luca CMG, Paoletti FP, Gaetani L, Moda F, Parnetti L (2022) Alpha- synuclein seed amplification assays for diagnosing synucleinopathies: the way forward. Neurology 99:195\u2013205","journal-title":"Neurology"},{"key":"10128_CR14","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0140-6736(23)01419-8","volume":"403","author":"Y Ben-Shlomo","year":"2024","unstructured":"Ben-Shlomo Y, Darweesh S, Llibre-Guerra J, Marras C, San Luciano M, Tanner C (2024) The epidemiology of Parkinson\u2019s disease. Lancet 403:283\u2013292","journal-title":"Lancet"},{"key":"10128_CR15","first-page":"344","volume":"50","author":"AL Benabid","year":"1987","unstructured":"Benabid AL, Pollak P, Louveau A, Henry S, de Rougemont J (1987) Combined (thalamotomy and stimulation) stereotactic surgery of the VIM thalamic nucleus for bilateral Parkinson disease. Appl Neurophysiol 50:344\u2013346","journal-title":"Appl Neurophysiol"},{"key":"10128_CR17","doi-asserted-by":"publisher","first-page":"2966","DOI":"10.1016\/j.celrep.2019.08.015","volume":"28","author":"AS Bhattacharjee","year":"2019","unstructured":"Bhattacharjee AS, Konakamchi S, Turaev D, Vincis R, Nunes D, Dingankar AA, Spors H, Carleton A, Kuner T, Abraham NM (2019) Similarity and strength of glomerular odor representations define a neural metric of Sniff-Invariant discrimination time. Cell Rep 28(11):2966\u20132978.e5","journal-title":"Cell Rep"},{"key":"10128_CR16","doi-asserted-by":"publisher","first-page":"100575","DOI":"10.1016\/j.eclinm.2020.100575","volume":"28","author":"AS Bhattacharjee","year":"2020","unstructured":"Bhattacharjee AS, Joshi SV, Naik S, Sangle S, Abraham NM (2020) Quantitative assessment of olfactory dysfunction accurately detects asymptomatic COVID-19 carriers. EClinicalMedicine 28:100575","journal-title":"EClinicalMedicine"},{"key":"10128_CR18","doi-asserted-by":"publisher","unstructured":"Bhowmik R, Pardasani M, Mahajan S, Bhattacharjee AS, Konakamchi S, Phadnis S, Musthafa T, McGowan E, Srikanth P, Marathe SD, Abraham NM (2022) Uncertainty revealed by delayed responses during olfactory matching. BioRxiv, 2022.09.11.507462. https:\/\/doi.org\/10.1101\/2022.09.11.507462","DOI":"10.1101\/2022.09.11.507462"},{"key":"10128_CR19","doi-asserted-by":"publisher","first-page":"100081","DOI":"10.1016\/j.crneur.2023.100081","volume":"4","author":"R Bhowmik","year":"2023","unstructured":"Bhowmik R, Pardasani M, Mahajan S, Magar R, Joshi SV, Nair GA, Bhattacharjee AS, Abraham NM (2023) Persistent olfactory learning deficits during and post-COVID-19 infection. Curr Res Neurobiol 4:100081","journal-title":"Curr Res Neurobiol"},{"key":"10128_CR20","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.nbd.2017.03.007","volume":"109","author":"G Bieri","year":"2018","unstructured":"Bieri G, Gitler AD, Brahic M (2018) Internalization, axonal transport and release of fibrillar forms of alpha-synuclein. Neurobiol Dis 109:219\u2013225","journal-title":"Neurobiol Dis"},{"key":"10128_CR21","first-page":"787","volume":"73","author":"W Birkmayer","year":"1961","unstructured":"Birkmayer W, Hornykiewicz O (1961) The L-3,4-dioxyphenylalanine (DOPA)-effect in Parkinson-akinesia. Wien Klin Wochenschr 73:787\u2013788","journal-title":"Wien Klin Wochenschr"},{"key":"10128_CR22","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s00401-015-1504-2","volume":"131","author":"C Bliederhaeuser","year":"2016","unstructured":"Bliederhaeuser C, Grozdanov V, Speidel A, Zondler L, Ruf WP, Bayer H, Kiechle M, Feiler MS, Freischmidt A, Brenner D, Witting A, Hengerer B, Fandrich M, Ludolph AC, Weishaupt JH, Gillardon F, Danzer KM (2016) Age-dependent defects of alpha-synuclein oligomer uptake in microglia and monocytes. Acta Neuropathol 131:379\u2013391","journal-title":"Acta Neuropathol"},{"key":"10128_CR23","doi-asserted-by":"publisher","first-page":"114020","DOI":"10.1016\/j.bbr.2022.114020","volume":"434","author":"A Bluhm","year":"2022","unstructured":"Bluhm A, Schrempel S, Moceri S, Stieler J, Feja M, Schilling S, Schulze A, von Horsten S, Hartlage-Rubsamen M, Richter F, Rossner S (2022) Alpha synuclein processing by MMP-3 - implications for synucleinopathies. Behav Brain Res 434:114020","journal-title":"Behav Brain Res"},{"key":"10128_CR24","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1007\/s00415-006-0284-y","volume":"254","author":"NI Bohnen","year":"2007","unstructured":"Bohnen NI, Gedela S, Kuwabara H, Constantine GM, Mathis CA, Studenski SA, Moore RY (2007) Selective hyposmia and nigrostriatal dopaminergic denervation in Parkinson\u2019s disease. J Neurol 254:84\u201390","journal-title":"J Neurol"},{"key":"10128_CR25","doi-asserted-by":"publisher","first-page":"290","DOI":"10.3389\/fnbeh.2014.00290","volume":"8","author":"A Bonito-Oliva","year":"2014","unstructured":"Bonito-Oliva A, Masini D, Fisone G (2014) A mouse model of non-motor symptoms in Parkinson\u2019s disease: focus on Pharmacological interventions targeting affective dysfunctions. Front Behav Neurosci 8:290","journal-title":"Front Behav Neurosci"},{"key":"10128_CR26","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging 24:197\u2013211","journal-title":"Neurobiol Aging"},{"key":"10128_CR27","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s00441-004-0956-9","volume":"318","author":"H Braak","year":"2004","unstructured":"Braak H, Ghebremedhin E, Rub U, Bratzke H, Del Tredici K (2004) Stages in the development of Parkinson\u2019s disease-related pathology. Cell Tissue Res 318:121\u2013134","journal-title":"Cell Tissue Res"},{"key":"10128_CR28","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3389\/fneur.2019.00122","volume":"10","author":"E Caggiu","year":"2019","unstructured":"Caggiu E, Arru G, Hosseini S, Niegowska M, Sechi G, Zarbo IR, Sechi LA (2019) Inflammation, infectious triggers, and Parkinson\u2019s disease. Front Neurol 10:122","journal-title":"Front Neurol"},{"key":"10128_CR29","doi-asserted-by":"publisher","first-page":"20220359","DOI":"10.1515\/tnsci-2022-0359","volume":"15","author":"H Cai","year":"2024","unstructured":"Cai H, Liu D, Xue WW, Ma L, Xie HT, Ning K (2024) Lipid-based nanoparticles for drug delivery in Parkinson\u2019s disease. Transl Neurosci 15:20220359","journal-title":"Transl Neurosci"},{"key":"10128_CR30","doi-asserted-by":"publisher","first-page":"581503","DOI":"10.3389\/fnins.2020.581503","volume":"14","author":"YO Cakmak","year":"2020","unstructured":"Cakmak YO, Nazim K, Thomas C, Datta A (2020) Optimized electrode placements for Non-invasive electrical stimulation of the olfactory bulb and olfactory mucosa. Front Neurosci 14:581503","journal-title":"Front Neurosci"},{"key":"10128_CR31","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/s41419-023-05672-9","volume":"14","author":"P Calabresi","year":"2023","unstructured":"Calabresi P, Mechelli A, Natale G, Volpicelli-Daley L, Di Lazzaro G, Ghiglieri V (2023) Alpha-synuclein in Parkinson\u2019s disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction. Cell Death Dis 14:176","journal-title":"Cell Death Dis"},{"key":"10128_CR32","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1038\/1801200a0","volume":"180","author":"A Carlsson","year":"1957","unstructured":"Carlsson A, Lindqvist M, Magnusson T (1957) 3,4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists. Nature 180:1200","journal-title":"Nature"},{"key":"10128_CR33","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1038\/s41467-021-21937-3","volume":"12","author":"R Cascella","year":"2021","unstructured":"Cascella R, Chen SW, Bigi A, Camino JD, Xu CK, Dobson CM, Chiti F, Cremades N, Cecchi C (2021) The release of toxic oligomers from \u03b1-synuclein fibrils induces dysfunction in neuronal cells. Nat Commun 12:1814","journal-title":"Nat Commun"},{"key":"10128_CR34","doi-asserted-by":"publisher","first-page":"447","DOI":"10.3389\/fneur.2020.00447","volume":"11","author":"BA Chase","year":"2020","unstructured":"Chase BA, Markopoulou K (2020) Olfactory dysfunction in Familial and sporadic Parkinson\u2019s disease. Front Neurol 11:447","journal-title":"Front Neurol"},{"key":"10128_CR35","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/s41531-021-00259-7","volume":"7","author":"F Chen","year":"2021","unstructured":"Chen F, Liu W, Liu P, Wang Z, Zhou Y, Liu X, Li A (2021a) alpha-Synuclein aggregation in the olfactory bulb induces olfactory deficits by perturbing granule cells and granular-mitral synaptic transmission. NPJ Parkinsons Dis 7:114","journal-title":"NPJ Parkinsons Dis"},{"key":"10128_CR37","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s13024-021-00497-6","volume":"16","author":"KS Chen","year":"2021","unstructured":"Chen KS, Menezes K, Rodgers JB, O\u2019Hara DM, Tran N, Fujisawa K, Ishikura S, Khodaei S, Chau H, Cranston A, Kapadia M, Pawar G, Ping S, Krizus A, Lacoste A, Spangler S, Visanji NP, Marras C, Majbour NK, El-Agnaf OMA, Lozano AM, Culotti J, Suo S, Ryu WS, Kalia SK, Kalia LV (2021b) Small molecule inhibitors of alpha-synuclein oligomers identified by targeting early dopamine-mediated motor impairment in C. elegans. Mol Neurodegener 16:77","journal-title":"Mol Neurodegener"},{"key":"10128_CR36","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13024-022-00560-w","volume":"17","author":"K Chen","year":"2022","unstructured":"Chen K, Martens YA, Meneses A, Ryu DH, Lu W, Raulin AC, Li F, Zhao J, Chen Y, Jin Y, Linares C, Goodwin M, Li Y, Liu CC, Kanekiyo T, Holtzman DM, Golde TE, Bu G, Zhao N (2022) LRP1 is a neuronal receptor for alpha-synuclein uptake and spread. Mol Neurodegener 17:57","journal-title":"Mol Neurodegener"},{"issue":"Suppl 4","key":"10128_CR38","doi-asserted-by":"publisher","first-page":"16419","DOI":"10.1073\/pnas.212527999","volume":"99","author":"F Chiti","year":"2002","unstructured":"Chiti F, Calamai M, Taddei N, Stefani M, Ramponi G, Dobson CM (2002) Studies of the aggregation of mutant proteins in vitro provide insights into the genetics of amyloid diseases. Proc Natl Acad Sci U S A 99(Suppl 4):16419\u201316426","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10128_CR40","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jns.2018.07.011","volume":"392","author":"JG Choi","year":"2018","unstructured":"Choi JG, Huh E, Ju IG, Kim N, Yun J, Oh MS (2018) 1-Methyl-4-phenyl-1,2,3,6 tetrahydropyridine\/probenecid impairs intestinal motility and olfaction in the early stages of Parkinson\u2019s disease in mice. J Neurol Sci 392:77\u201382","journal-title":"J Neurol Sci"},{"key":"10128_CR39","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1038\/s41467-020-15119-w","volume":"11","author":"I Choi","year":"2020","unstructured":"Choi I, Zhang Y, Seegobin SP, Pruvost M, Wang Q, Purtell K, Zhang B, Yue Z (2020) Microglia clear neuron-released alpha-synuclein via selective autophagy and prevent neurodegeneration. Nat Commun 11:1386","journal-title":"Nat Commun"},{"key":"10128_CR41","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.matbio.2013.10.004","volume":"35","author":"HC Christianson","year":"2014","unstructured":"Christianson HC, Belting M (2014) Heparan sulfate proteoglycan as a cell-surface endocytosis receptor. Matrix Biol 35:51\u201355","journal-title":"Matrix Biol"},{"key":"10128_CR42","doi-asserted-by":"crossref","unstructured":"Cole TA, Zhao H, Collier TJ, Sandoval I, Sortwell CE, Steece-Collier K, Daley BF, Booms A, Lipton J, Welch M, Berman M, Jandreski L, Graham D, Weihofen A, Celano S, Schulz E, Cole-Strauss A, Luna E, Quach D, Mohan A, Bennett CF, Swayze EE, Kordasiewicz HB, Luk KC, Paumier KL (2021) Alpha-synuclein antisense oligonucleotides as a disease-modifying therapy for Parkinson\u2019s disease. JCI Insight 6(5):e135633","DOI":"10.1172\/jci.insight.135633"},{"key":"10128_CR43","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1002\/mds.29329","volume":"38","author":"L Concha-Marambio","year":"2023","unstructured":"Concha-Marambio L, Weber S, Farris CM, Dakna M, Lang E, Wicke T, Ma Y, Starke M, Ebentheuer J, Sixel-D\u00f6ring F, Muntean ML, Schade S, Trenkwalder C, Soto C, Mollenhauer B (2023) Accurate detection of \u03b1-synuclein seeds in cerebrospinal fluid from isolated rapid eye movement sleep behavior disorder and patients with Parkinson\u2019s disease in the DeNovo Parkinson (DeNoPa) cohort. Mov Disord 38:567\u2013578","journal-title":"Mov Disord"},{"key":"10128_CR44","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1093\/chemse\/bjt072","volume":"39","author":"I Croy","year":"2014","unstructured":"Croy I, Nordin S, Hummel T (2014) Olfactory disorders and quality of life\u2013an updated review. Chem Senses 39:185\u2013194","journal-title":"Chem Senses"},{"key":"10128_CR45","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/s41531-024-00804-0","volume":"10","author":"AD Currie","year":"2024","unstructured":"Currie AD, Wong JK, Okun MS (2024) A review of Temporal interference, nanoparticles, ultrasound, gene therapy, and designer receptors for Parkinson disease. NPJ Parkinsons Dis 10:195","journal-title":"NPJ Parkinsons Dis"},{"key":"10128_CR46","doi-asserted-by":"publisher","first-page":"101416","DOI":"10.1016\/j.arr.2021.101416","volume":"70","author":"X Dan","year":"2021","unstructured":"Dan X, Wechter N, Gray S, Mohanty JG, Croteau DL, Bohr VA (2021) Olfactory dysfunction in aging and neurodegenerative diseases. Ageing Res Rev 70:101416","journal-title":"Ageing Res Rev"},{"key":"10128_CR47","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1128\/CMR.00118-13","volume":"27","author":"SJ Dando","year":"2014","unstructured":"Dando SJ, Mackay-Sim A, Norton R, Currie BJ, St John JA, Ekberg JA, Batzloff M, Ulett GC, Beacham IR (2014) Pathogens penetrating the central nervous system: infection pathways and the cellular and molecular mechanisms of invasion. Clin Microbiol Rev 27:691\u2013726","journal-title":"Clin Microbiol Rev"},{"key":"10128_CR48","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/1750-1326-7-42","volume":"7","author":"KM Danzer","year":"2012","unstructured":"Danzer KM, Kranich LR, Ruf WP, Cagsal-Getkin O, Winslow AR, Zhu L, Vanderburg CR, McLean PJ (2012) Exosomal cell-to-cell transmission of alpha synuclein oligomers. Mol Neurodegener 7:42","journal-title":"Mol Neurodegener"},{"key":"10128_CR49","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","volume":"39","author":"W Dauer","year":"2003","unstructured":"Dauer W, Przedborski S (2003) Parkinson\u2019s disease: mechanisms and models. Neuron 39:889\u2013909","journal-title":"Neuron"},{"key":"10128_CR50","doi-asserted-by":"crossref","first-page":"205520762211290","DOI":"10.1177\/20552076221129061","volume":"8","author":"N Desai","year":"2022","unstructured":"Desai N, Maggioni E, Obrist M, Orlu M (2022) Scent-delivery devices as a digital healthcare tool for olfactory training: A pilot focus group study in Parkinson\u2019s disease patients. Digit Health 8:20552076221129061","journal-title":"Digit Health"},{"key":"10128_CR51","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1124\/jpet.108.145565","volume":"328","author":"SV Dhuria","year":"2009","unstructured":"Dhuria SV, Hanson LR, Frey WH 2nd (2009) Novel vasoconstrictor formulation to enhance intranasal targeting of neuropeptide therapeutics to the central nervous system. J Pharmacol Exp Ther 328:312\u2013320","journal-title":"J Pharmacol Exp Ther"},{"key":"10128_CR52","doi-asserted-by":"crossref","first-page":"342ra378","DOI":"10.1126\/scitranslmed.aaf3634","volume":"8","author":"R Di Maio","year":"2016","unstructured":"Di Maio R, Barrett PJ, Hoffman EK, Barrett CW, Zharikov A, Borah A, Hu X, McCoy J, Chu CT, Burton EA, Hastings TG, Greenamyre JT (2016) Alpha-synuclein binds to TOM20 and inhibits mitochondrial protein import in Parkinson\u2019s disease. Sci Transl Med 8:342ra378","journal-title":"Sci Transl Med"},{"key":"10128_CR53","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.bbr.2014.08.024","volume":"274","author":"BT DiBenedictis","year":"2014","unstructured":"DiBenedictis BT, Olugbemi AO, Baum MJ, Cherry JA (2014) 6-Hydroxydopamine lesions of the anteromedial ventral striatum impair opposite-sex urinary odor preference in female mice. Behav Brain Res 274:243\u2013247","journal-title":"Behav Brain Res"},{"key":"10128_CR54","doi-asserted-by":"publisher","first-page":"e3001287","DOI":"10.1371\/journal.pbio.3001287","volume":"19","author":"A Dilsizoglu Senol","year":"2021","unstructured":"Dilsizoglu Senol A, Samarani M, Syan S, Guardia CM, Nonaka T, Liv N, Latour-Lambert P, Hasegawa M, Klumperman J, Bonifacino JS, Zurzolo C (2021) Alpha- synuclein fibrils subvert lysosome structure and function for the propagation of protein misfolding between cells through tunneling nanotubes. PLoS Biol 19:e3001287","journal-title":"PLoS Biol"},{"key":"10128_CR55","doi-asserted-by":"publisher","first-page":"11750","DOI":"10.1523\/JNEUROSCI.0234-12.2012","volume":"32","author":"MJ Diogenes","year":"2012","unstructured":"Diogenes MJ, Dias RB, Rombo DM, Vicente Miranda H, Maiolino F, Guerreiro P, Nasstrom T, Franquelim HG, Oliveira LM, Castanho MA, Lannfelt L, Bergstrom J, Ingelsson M, Quintas A, Sebastiao AM, Lopes LV, Outeiro TF (2012) Extracellular alpha-synuclein oligomers modulate synaptic transmission and impair LTP via NMDA-receptor activation. J Neurosci 32:11750\u201311762","journal-title":"J Neurosci"},{"key":"10128_CR56","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/S0006-8993(96)00934-1","volume":"741","author":"DE Dluzen","year":"1996","unstructured":"Dluzen DE, Kefalas G (1996) The effects of intranasal infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) upon catecholamine concentrations within olfactory bulbs and corpus striatum of male mice. Brain Res 741:215\u2013219","journal-title":"Brain Res"},{"key":"10128_CR57","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1017\/CBO9780511543623.015","volume-title":"Olfaction and the brain","author":"RL Doty","year":"2006","unstructured":"Doty RL (2006) Assessment of olfaction. In: Brewer WJ, Castle D, Pantelis C (eds) Olfaction and the brain. Cambridge University Press, Cambridge, pp 235\u2013258"},{"key":"10128_CR58","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nrneurol.2012.80","volume":"8","author":"RL Doty","year":"2012","unstructured":"Doty RL (2012) Olfactory dysfunction in Parkinson disease. Nat Rev Neurol 8:329\u2013339","journal-title":"Nat Rev Neurol"},{"key":"10128_CR59","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.wjorl.2015.09.007","volume":"1","author":"RL Doty","year":"2015","unstructured":"Doty RL (2015) Olfactory dysfunction and its measurement in the clinic. World J Otorhinolaryngol Head Neck Surg 1:28\u201333","journal-title":"World J Otorhinolaryngol Head Neck Surg"},{"key":"10128_CR60","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.wjorl.2018.03.001","volume":"4","author":"RL Doty","year":"2018","unstructured":"Doty RL (2018) Measurement of chemosensory function. World J Otorhinolaryngol Head Neck Surg 4:11\u201328","journal-title":"World J Otorhinolaryngol Head Neck Surg"},{"key":"10128_CR61","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1001\/archneur.60.4.545","volume":"60","author":"KL Double","year":"2003","unstructured":"Double KL, Rowe DB, Hayes M, Chan DK, Blackie J, Corbett A, Joffe R, Fung VS, Morris J, Halliday GM (2003) Identifying the pattern of olfactory deficits in Parkinson disease using the brief smell identification test. Arch Neurol 60:545\u2013549","journal-title":"Arch Neurol"},{"key":"10128_CR62","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s40035-023-00368-8","volume":"12","author":"A Dovonou","year":"2023","unstructured":"Dovonou A, Bolduc C, Soto Linan V, Gora C, Peralta Iii MR, L\u00e9vesque M (2023) Animal models of Parkinson\u2019s disease: bridging the gap between disease hallmarks and research questions. Translational Neurodegeneration 12:36","journal-title":"Translational Neurodegeneration"},{"key":"10128_CR64","doi-asserted-by":"publisher","first-page":"8645","DOI":"10.3390\/ijms21228645","volume":"21","author":"X-Y Du","year":"2020","unstructured":"Du X-Y, Xie X-X, Liu R-T (2020) The role of \u03b1-Synuclein oligomers in Parkinson\u2019s disease. Int J Mol Sci 21:8645","journal-title":"Int J Mol Sci"},{"key":"10128_CR63","doi-asserted-by":"publisher","first-page":"645996","DOI":"10.3389\/fnagi.2021.645996","volume":"13","author":"T Du","year":"2021","unstructured":"Du T, Wang L, Liu W, Zhu G, Chen Y, Zhang J (2021) Biomarkers and the role of alpha-synuclein in Parkinson\u2019s disease. Front Aging Neurosci 13:645996","journal-title":"Front Aging Neurosci"},{"key":"10128_CR65","doi-asserted-by":"publisher","first-page":"29","DOI":"10.4103\/1735-1995.181989","volume":"21","author":"FN Emamzadeh","year":"2016","unstructured":"Emamzadeh FN (2016) Alpha-synuclein structure, functions, and interactions. J Res Med Sciences: Official J Isfahan Univ Med Sci 21:29\u201329","journal-title":"J Res Med Sciences: Official J Isfahan Univ Med Sci"},{"issue":"Suppl 1","key":"10128_CR66","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/jnc.13618","volume":"139","author":"BH Falkenburger","year":"2016","unstructured":"Falkenburger BH, Saridaki T, Dinter E (2016) Cellular models for Parkinson\u2019s disease. J Neurochem 139(Suppl 1):121\u2013130","journal-title":"J Neurochem"},{"key":"10128_CR67","doi-asserted-by":"crossref","unstructured":"Fang C, Lv L, Mao S, Dong H, Liu B (2020) Cognition Deficits in Parkinson\u2019s Disease: Mechanisms and Treatment. Parkinsons Dis 2020, 2076942","DOI":"10.1155\/2020\/2076942"},{"key":"10128_CR68","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1111\/jnc.12481","volume":"128","author":"KF Farrell","year":"2014","unstructured":"Farrell KF, Krishnamachari S, Villanueva E, Lou H, Alerte TN, Peet E, Drolet RE, Perez RG (2014) Non-motor parkinsonian pathology in aging A53T alpha-synuclein mice is associated with progressive synucleinopathy and altered enzymatic function. J Neurochem 128:536\u2013546","journal-title":"J Neurochem"},{"key":"10128_CR69","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1474-4422(18)30499-X","volume":"18","author":"VL Feigin","year":"2019","unstructured":"Feigin VL, Nichols E, Alam T, Naghavi M, Murray CJL, Vos T (2019) Global, regional, and National burden of neurological disorders, 1990\u20132016: a systematic analysis for the global burden of disease study 2016. Lancet Neurol 18:459\u2013480","journal-title":"Lancet Neurol"},{"key":"10128_CR70","doi-asserted-by":"publisher","first-page":"105807","DOI":"10.1016\/j.parkreldis.2023.105807","volume":"117","author":"B Fernandes Gomes","year":"2023","unstructured":"Fernandes Gomes B, Farris CM, Ma Y, Concha-Marambio L, Lebovitz R, Nellgard B, Dalla K, Constantinescu J, Constantinescu R, Gobom J, Andreasson U, Zetterberg H, Blennow K (2023) Alpha-synuclein seed amplification assay as a diagnostic tool for parkinsonian disorders. Parkinsonism Relat Disord 117:105807","journal-title":"Parkinsonism Relat Disord"},{"key":"10128_CR71","doi-asserted-by":"publisher","first-page":"369","DOI":"10.3389\/fnins.2019.00369","volume":"13","author":"E Fitzgerald","year":"2019","unstructured":"Fitzgerald E, Murphy S, Martinson HA (2019) Alpha-synuclein pathology and the role of the microbiota in Parkinson\u2019s disease. Front Neurosci 13:369","journal-title":"Front Neurosci"},{"key":"10128_CR72","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1002\/ana.23747","volume":"72","author":"EC Freundt","year":"2012","unstructured":"Freundt EC, Maynard N, Clancy EK, Roy S, Bousset L, Sourigues Y, Covert M, Melki R, Kirkegaard K, Brahic M (2012) Neuron-to-neuron transmission of alpha-synuclein fibrils through axonal transport. Ann Neurol 72:517\u2013524","journal-title":"Ann Neurol"},{"key":"10128_CR73","doi-asserted-by":"publisher","first-page":"4001","DOI":"10.1021\/acsomega.1c05060","volume":"7","author":"W Fu","year":"2022","unstructured":"Fu W, Xu L, Yu Q, Fang J, Zhao G, Li Y, Pan C, Dong H, Wang D, Ren H, Guo Y, Liu Q, Liu J, Chen X (2022) Artificial intelligent olfactory system for the diagnosis of Parkinson\u2019s disease. ACS Omega 7:4001\u20134010","journal-title":"ACS Omega"},{"key":"10128_CR74","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/ncb748","volume":"4","author":"H Fujiwara","year":"2002","unstructured":"Fujiwara H, Hasegawa M, Dohmae N, Kawashima A, Masliah E, Goldberg MS, Shen J, Takio K, Iwatsubo T (2002) Alpha-synuclein is phosphorylated in synucleinopathy lesions. Nat Cell Biol 4:160\u2013164","journal-title":"Nat Cell Biol"},{"key":"10128_CR76","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.parkreldis.2016.02.013","volume":"25","author":"ME Fullard","year":"2016","unstructured":"Fullard ME, Tran B, Xie SX, Toledo JB, Scordia C, Linder C, Purri R, Weintraub D, Duda JE, Chahine LM, Morley JF (2016) Olfactory impairment predicts cognitive decline in early Parkinson\u2019s disease. Parkinsonism Relat Disord 25:45\u201351","journal-title":"Parkinsonism Relat Disord"},{"key":"10128_CR75","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s12264-017-0170-x","volume":"33","author":"ME Fullard","year":"2017","unstructured":"Fullard ME, Morley JF, Duda JE (2017) Olfactory dysfunction as an early biomarker in Parkinson\u2019s disease. Neurosci Bull 33:515\u2013525","journal-title":"Neurosci Bull"},{"key":"10128_CR77","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/s10038-022-01058-5","volume":"68","author":"M Funayama","year":"2023","unstructured":"Funayama M, Nishioka K, Li Y, Hattori N (2023) Molecular genetics of Parkinson\u2019s disease: contributions and global trends. J Hum Genet 68:125\u2013130","journal-title":"J Hum Genet"},{"key":"10128_CR78","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1126\/science.aan6160","volume":"358","author":"G Fusco","year":"2017","unstructured":"Fusco G, Chen SW, Williamson PTF, Cascella R, Perni M, Jarvis JA, Cecchi C, Vendruscolo M, Chiti F, Cremades N, Ying L, Dobson CM, De Simone A (2017) Structural basis of membrane disruption and cellular toxicity by alpha-synuclein oligomers. Science 358:1440\u20131443","journal-title":"Science"},{"key":"10128_CR79","doi-asserted-by":"publisher","first-page":"9441","DOI":"10.1523\/JNEUROSCI.5314-13.2014","volume":"34","author":"D Games","year":"2014","unstructured":"Games D, Valera E, Spencer B, Rockenstein E, Mante M, Adame A, Patrick C, Ubhi K, Nuber S, Sacayon P, Zago W, Seubert P, Barbour R, Schenk D, Masliah E (2014) Reducing C-terminal-truncated alpha-synuclein by immunotherapy attenuates neurodegeneration and propagation in Parkinson\u2019s disease-like models. J Neurosci 34:9441\u20139454","journal-title":"J Neurosci"},{"key":"10128_CR80","doi-asserted-by":"crossref","unstructured":"Genter MB, Doty RL (2019) Chap. 22 - Toxic exposures and the senses of taste and smell. In: Doty RL (ed) Handbook of clinical neurology. Elsevier, pp 389\u2013408","DOI":"10.1016\/B978-0-444-63855-7.00022-8"},{"key":"10128_CR81","doi-asserted-by":"publisher","first-page":"9228","DOI":"10.1038\/srep09228","volume":"5","author":"D Ghosh","year":"2015","unstructured":"Ghosh D, Singh PK, Sahay S, Jha NN, Jacob RS, Sen S, Kumar A, Riek R, Maji SK (2015) Structure based aggregation studies reveal the presence of helix-rich intermediate during \u03b1-synuclein aggregation. Sci Rep 5:9228","journal-title":"Sci Rep"},{"key":"10128_CR82","doi-asserted-by":"crossref","unstructured":"Gittis AH, Sillitoe RV (2024) Circuit-Specific deep brain stimulation provides insights into movement control. Annu Rev Neurosci 47:63\u201383","DOI":"10.1146\/annurev-neuro-092823-104810"},{"key":"10128_CR83","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.expneurol.2012.01.002","volume":"235","author":"L Glasl","year":"2012","unstructured":"Glasl L, Kloos K, Giesert F, Roethig A, Di Benedetto B, Kuhn R, Zhang J, Hafen U, Zerle J, Hofmann A, de Angelis MH, Winklhofer KF, Holter SM, Vogt Weisenhorn DM, Wurst W (2012) Pink1-deficiency in mice impairs gait, olfaction and serotonergic innervation of the olfactory bulb. Exp Neurol 235:214\u2013227","journal-title":"Exp Neurol"},{"key":"10128_CR84","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/35081564","volume":"2","author":"M Goedert","year":"2001","unstructured":"Goedert M (2001) Alpha-synuclein and neurodegenerative diseases. Nat Rev Neurosci 2:492\u2013501","journal-title":"Nat Rev Neurosci"},{"key":"10128_CR85","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.stemcr.2018.12.007","volume":"12","author":"S Gribaudo","year":"2019","unstructured":"Gribaudo S, Tixador P, Bousset L, Fenyi A, Lino P, Melki R, Peyrin JM, Perrier AL (2019) Propagation of alpha-synuclein strains within human reconstructed neuronal network. Stem Cell Rep 12:230\u2013244","journal-title":"Stem Cell Rep"},{"key":"10128_CR86","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1177\/1756285609339382","volume":"2","author":"SJ Groiss","year":"2009","unstructured":"Groiss SJ, Wojtecki L, Sudmeyer M, Schnitzler A (2009) Deep brain stimulation in Parkinson\u2019s disease. Ther Adv Neurol Disord 2:20\u201328","journal-title":"Ther Adv Neurol Disord"},{"key":"10128_CR87","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1038\/nn.4089","volume":"18","author":"O Gschwend","year":"2015","unstructured":"Gschwend O, Abraham NM, Lagier S, Begnaud F, Rodriguez I, Carleton A (2015) Neuronal pattern separation in the olfactory bulb improves odor discrimination learning. Nat Neurosci 18(10):1474\u20131482","journal-title":"Nat Neurosci"},{"key":"10128_CR88","doi-asserted-by":"publisher","first-page":"583","DOI":"10.4103\/1673-5374.380875","volume":"19","author":"Y Gu","year":"2024","unstructured":"Gu Y, Zhang J, Zhao X, Nie W, Xu X, Liu M, Zhang X (2024) Olfactory dysfunction and its related molecular mechanisms in Parkinson\u2019s disease. Neural Regen Res 19:583\u2013590","journal-title":"Neural Regen Res"},{"key":"10128_CR89","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1586\/ern.09.115","volume":"9","author":"A Haehner","year":"2009","unstructured":"Haehner A, Hummel T, Reichmann H (2009) Olfactory dysfunction as a diagnostic marker for Parkinson\u2019s disease. Expert Rev Neurother 9:1773\u20131779","journal-title":"Expert Rev Neurother"},{"key":"10128_CR90","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.brainres.2011.02.041","volume":"1386","author":"Y Han","year":"2011","unstructured":"Han Y, Khodr CE, Sapru MK, Pedapati J, Bohn MC (2011) A MicroRNA embedded AAV alpha-synuclein gene silencing vector for dopaminergic neurons. Brain Res 1386:15\u201324","journal-title":"Brain Res"},{"key":"10128_CR91","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1172\/JCI43366","volume":"121","author":"C Hansen","year":"2011","unstructured":"Hansen C, Angot E, Bergstrom AL, Steiner JA, Pieri L, Paul G, Outeiro TF, Melki R, Kallunki P, Fog K, Li JY, Brundin P (2011) Alpha-synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells. J Clin Invest 121:715\u2013725","journal-title":"J Clin Invest"},{"key":"10128_CR92","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.nbd.2013.04.017","volume":"56","author":"C Hansen","year":"2013","unstructured":"Hansen C, Bjorklund T, Petit GH, Lundblad M, Murmu RP, Brundin P, Li JY (2013) A novel alpha-synuclein-GFP mouse model displays progressive motor impairment, olfactory dysfunction and accumulation of alpha-synuclein-GFP. Neurobiol Dis 56:145\u2013155","journal-title":"Neurobiol Dis"},{"key":"10128_CR93","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s00401-021-02349-5","volume":"142","author":"M Hartlage-Rubsamen","year":"2021","unstructured":"Hartlage-Rubsamen M, Bluhm A, Moceri S, Machner L, Koppen J, Schenk M, Hilbrich I, Holzer M, Weidenfeller M, Richter F, Coras R, Serrano GE, Beach TG, Schilling S, von Horsten S, Xiang W, Schulze A, Rossner S (2021) A glutaminyl cyclase-catalyzed alpha-synuclein modification identified in human synucleinopathies. Acta Neuropathol 142:399\u2013421","journal-title":"Acta Neuropathol"},{"key":"10128_CR94","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1124\/pharmrev.123.001111","volume":"76","author":"K Hassanzadeh","year":"2024","unstructured":"Hassanzadeh K, Liu J, Maddila S, Mouradian MM (2024) Posttranslational modifications of alpha-Synuclein, their therapeutic potential, and crosstalk in health and neurodegenerative diseases. Pharmacol Rev 76:1254\u20131290","journal-title":"Pharmacol Rev"},{"key":"10128_CR95","doi-asserted-by":"crossref","unstructured":"Henrich MT, Geibl FF, Lakshminarasimhan H, Stegmann A, Giasson BI, Mao X, Dawson VL, Dawson TM, Oertel WH, Surmeier DJ (2020) Determinants of seeding and spreading of alpha-synuclein pathology in the brain. Sci Adv 6","DOI":"10.1126\/sciadv.abc2487"},{"key":"10128_CR96","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s00415-008-0665-5","volume":"255","author":"B Herting","year":"2008","unstructured":"Herting B, Schulze S, Reichmann H, Haehner A, Hummel T (2008) A longitudinal study of olfactory function in patients with idiopathic Parkinson\u2019s disease. J Neurol 255:367\u2013370","journal-title":"J Neurol"},{"key":"10128_CR97","doi-asserted-by":"crossref","unstructured":"Hickey P, Stacy M (2016) Deep Brain Stimulation: A Paradigm Shifting Approach to Treat Parkinson\u2019s Disease. Frontiers in Neuroscience 10","DOI":"10.3389\/fnins.2016.00173"},{"key":"10128_CR98","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s00401-015-1451-y","volume":"130","author":"GU Hoglinger","year":"2015","unstructured":"Hoglinger GU, Alvarez-Fischer D, Arias-Carrion O, Djufri M, Windolph A, Keber U, Borta A, Ries V, Schwarting RK, Scheller D, Oertel WH (2015) A new dopaminergic nigro-olfactory projection. Acta Neuropathol 130:333\u2013348","journal-title":"Acta Neuropathol"},{"key":"10128_CR99","doi-asserted-by":"publisher","first-page":"E3138","DOI":"10.1073\/pnas.1301440110","volume":"110","author":"BB Holmes","year":"2013","unstructured":"Holmes BB, DeVos SL, Kfoury N, Li M, Jacks R, Yanamandra K, Ouidja MO, Brodsky FM, Marasa J, Bagchi DP, Kotzbauer PT, Miller TM, Papy-Garcia D, Diamond MI (2013) Heparan sulfate proteoglycans mediate internalization and propagation of specific proteopathic seeds. Proc Natl Acad Sci U S A 110:E3138\u20133147","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10128_CR100","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1111\/bpa.12369","volume":"27","author":"A Hoshi","year":"2017","unstructured":"Hoshi A, Tsunoda A, Tada M, Nishizawa M, Ugawa Y, Kakita A (2017) Expression of Aquaporin 1 and Aquaporin 4 in the Temporal neocortex of patients with Parkinson\u2019s disease. Brain Pathol 27:160\u2013168","journal-title":"Brain Pathol"},{"key":"10128_CR101","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12974-020-01823-3","volume":"17","author":"L Hou","year":"2020","unstructured":"Hou L, Qu X, Qiu X, Huang R, Zhao X, Wang Q (2020) Integrin CD11b mediates locus coeruleus noradrenergic neurodegeneration in a mouse Parkinson\u2019s disease model. J Neuroinflammation 17:148","journal-title":"J Neuroinflammation"},{"key":"10128_CR102","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3389\/fnins.2019.00028","volume":"13","author":"M Huang","year":"2019","unstructured":"Huang M, Wang B, Li X, Fu C, Wang C, Kang X (2019) alpha-Synuclein: A multifunctional player in exocytosis, endocytosis, and vesicle recycling. Front Neurosci 13:28","journal-title":"Front Neurosci"},{"key":"10128_CR103","doi-asserted-by":"publisher","first-page":"1341295","DOI":"10.3389\/fnagi.2023.1341295","volume":"15","author":"Q Huang","year":"2023","unstructured":"Huang Q, Chen X, Yu S, Gong G, Shu H (2023) Research progress in brain-targeted nasal drug delivery. Front Aging Neurosci 15:1341295","journal-title":"Front Aging Neurosci"},{"key":"10128_CR104","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41531-024-00633-1","volume":"10","author":"YM Huang","year":"2024","unstructured":"Huang YM, Ma YH, Gao PY, Cui XH, Hou JH, Chi HC, Fu Y, Wang ZB, Feng JF, Cheng W, Tan L, Yu JT (2024) Genetic susceptibility modifies the association of long-term air pollution exposure on Parkinson\u2019s disease. NPJ Parkinsons Dis 10:23","journal-title":"NPJ Parkinsons Dis"},{"key":"10128_CR105","doi-asserted-by":"crossref","unstructured":"Hummel T, Podlesek D (2021) Clinical assessment of olfactory function. Chem Senses 46:bjab053","DOI":"10.1093\/chemse\/bjab053"},{"key":"10128_CR108","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1093\/chemse\/22.1.39","volume":"22","author":"T Hummel","year":"1997","unstructured":"Hummel T, Sekinger B, Wolf SR, Pauli E, Kobal G (1997) Sniffin\u2019 sticks\u2019: olfactory performance assessed by the combined testing of odor identification, odor discrimination and olfactory threshold. Chem Senses 22:39\u201352","journal-title":"Chem Senses"},{"key":"10128_CR107","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1002\/lary.20101","volume":"119","author":"T Hummel","year":"2009","unstructured":"Hummel T, Rissom K, Reden J, Hahner A, Weidenbecher M, Huttenbrink KB (2009) Effects of olfactory training in patients with olfactory loss. Laryngoscope 119:496\u2013499","journal-title":"Laryngoscope"},{"key":"10128_CR106","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1055\/a-1957-3267","volume":"102","author":"T Hummel","year":"2023","unstructured":"Hummel T, Power Guerra N, Gunder N, H\u00e4hner A, Menzel S (2023) Olfactory function and olfactory disorders. Laryngorhinootologie 102:S67\u2013s92","journal-title":"Laryngorhinootologie"},{"key":"10128_CR109","doi-asserted-by":"publisher","first-page":"1172416","DOI":"10.3389\/fneur.2023.1172416","volume":"14","author":"S Iacono","year":"2023","unstructured":"Iacono S, Schiro G, Davi C, Mastrilli S, Abbott M, Guajana F, Arnao V, Aridon P, Ragonese P, Gagliardo C, Colomba C, Scichilone N, D\u2019Amelio M (2023) COVID-19 and neurological disorders: what might connect Parkinson\u2019s disease to SARS-CoV-2 infection. Front Neurol 14:1172416","journal-title":"Front Neurol"},{"key":"10128_CR110","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/s41467-020-14520-9","volume":"11","author":"B Iravani","year":"2020","unstructured":"Iravani B, Arshamian A, Ohla K, Wilson DA, Lundstr\u00f6m JN (2020) Non-invasive recording from the human olfactory bulb. Nat Commun 11:648","journal-title":"Nat Commun"},{"key":"10128_CR111","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41531-021-00220-8","volume":"7","author":"B Iravani","year":"2021","unstructured":"Iravani B, Arshamian A, Schaefer M, Svenningsson P, Lundstrom JN (2021) A non-invasive olfactory bulb measure dissociates Parkinson\u2019s patients from healthy controls and discloses disease duration. NPJ Parkinsons Dis 7:75","journal-title":"NPJ Parkinsons Dis"},{"key":"10128_CR112","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1016\/S0140-6736(18)32279-7","volume":"392","author":"SL James","year":"2018","unstructured":"James SL, Abate D, Abate KH, Vos T, Murray CJL (2018) Global, regional, and National incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990\u20132017: a systematic analysis for the global burden of disease study 2017. Lancet 392:1789\u20131858","journal-title":"Lancet"},{"key":"10128_CR113","doi-asserted-by":"crossref","unstructured":"Kalyn M, Hua K, Mohd Noor S, Wong CED, Ekker M (2019) Comprehensive Analysis of Neurotoxin-Induced Ablation of Dopaminergic Neurons in Zebrafish Larvae. Biomedicines 8","DOI":"10.3390\/biomedicines8010001"},{"key":"10128_CR114","doi-asserted-by":"crossref","unstructured":"Kamath V, Jiang K, Manning KJ, Mackin RS, Walker KA, Powell D, Lin FR, Chen H, Brenowitz WD, Yaffe K, Simonsick EM, Deal JA (2024) Olfactory dysfunction and depression trajectories in Community-Dwelling older adults. J Gerontol Biol Sci Med Sci 79","DOI":"10.1093\/gerona\/glad139"},{"key":"10128_CR115","doi-asserted-by":"publisher","first-page":"106072","DOI":"10.1016\/j.parkreldis.2024.106072","volume":"122","author":"K Kawabata","year":"2024","unstructured":"Kawabata K, Bagarinao E, Seppi K, Poewe W (2024) Longitudinal brain changes in Parkinson\u2019s disease with severe olfactory deficit. Parkinsonism Relat Disord 122:106072","journal-title":"Parkinsonism Relat Disord"},{"key":"10128_CR116","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1152\/jn.00255.2022","volume":"128","author":"LM Kay","year":"2022","unstructured":"Kay LM (2022) COVID-19 and olfactory dysfunction: a looming wave of dementia? J Neurophysiol 128:436\u2013444","journal-title":"J Neurophysiol"},{"key":"10128_CR117","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.jconrel.2017.09.001","volume":"268","author":"AR Khan","year":"2017","unstructured":"Khan AR, Liu M, Khan MW, Zhai G (2017) Progress in brain targeting drug delivery system by nasal route. J Control Release 268:364\u2013389","journal-title":"J Control Release"},{"key":"10128_CR118","doi-asserted-by":"crossref","unstructured":"Khan E, Hasan I, Haque ME (2023) Parkinson\u2019s disease: exploring different animal model systems. Int J Mol Sci 24(10):9088","DOI":"10.3390\/ijms24109088"},{"key":"10128_CR119","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41531-019-0095-3","volume":"5","author":"BA Killinger","year":"2019","unstructured":"Killinger BA, Melki R, Brundin P, Kordower JH (2019) Endogenous alpha-synuclein monomers, oligomers and resulting pathology: let\u2019s talk about the lipids in the room. NPJ Parkinsons Dis 5:23","journal-title":"NPJ Parkinsons Dis"},{"key":"10128_CR120","doi-asserted-by":"crossref","unstructured":"Kim MS, Yoon S, Choi J, Kim YJ, Lee G (2024) Stem cell-based approaches in Parkinson\u2019s disease research. Int J Stem Cells 18(1):21\u201336","DOI":"10.15283\/ijsc23169"},{"key":"10128_CR121","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.parkreldis.2016.11.010","volume":"35","author":"F Krismer","year":"2017","unstructured":"Krismer F, Pinter B, Mueller C, Mahlknecht P, Nocker M, Reiter E, Djamshidian-Tehrani A, Boesch SM, Wenning GK, Scherfler C, Poewe W, Seppi K (2017) Sniffing the diagnosis: olfactory testing in neurodegenerative parkinsonism. Parkinsonism Relat Disord 35:36\u201341","journal-title":"Parkinsonism Relat Disord"},{"key":"10128_CR122","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/ng0298-106","volume":"18","author":"R Kruger","year":"1998","unstructured":"Kruger R, Kuhn W, Muller T, Woitalla D, Graeber M, Kosel S, Przuntek H, Epplen JT, Schols L, Riess O (1998) Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson\u2019s disease. Nat Genet 18:106\u2013108","journal-title":"Nat Genet"},{"key":"10128_CR123","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1083\/jcb.201010117","volume":"194","author":"P Krumova","year":"2011","unstructured":"Krumova P, Meulmeester E, Garrido M, Tirard M, Hsiao HH, Bossis G, Urlaub H, Zweckstetter M, Kugler S, Melchior F, Bahr M, Weishaupt JH (2011) Sumoylation inhibits alpha-synuclein aggregation and toxicity. J Cell Biol 194:49\u201360","journal-title":"J Cell Biol"},{"key":"10128_CR124","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.3233\/JPD-202241","volume":"10","author":"AS Kulkarni","year":"2020","unstructured":"Kulkarni AS, Del Mar Cortijo M, Roberts ER, Suggs TL, Stover HB, Pena-Bravo JI, Steiner JA, Luk KC, Brundin P, Wesson DW (2020) Perturbation of in vivo neural activity following \u03b1-synuclein seeding in the olfactory bulb. J Parkinsons Dis 10:1411\u20131427","journal-title":"J Parkinsons Dis"},{"key":"10128_CR125","doi-asserted-by":"crossref","unstructured":"Kumari P, Ghosh D, Vanas A, Fleischmann Y, Wiegand T, Jeschke G, Riek R, Eichmann C (2021) Structural insights into alpha-synuclein monomer-fibril interactions. Proc Natl Acad Sci USA 118(10):e2012171118","DOI":"10.1073\/pnas.2012171118"},{"key":"10128_CR126","doi-asserted-by":"publisher","first-page":"64","DOI":"10.14802\/jmd.23105","volume":"17","author":"IH Kwak","year":"2024","unstructured":"Kwak IH, Kim YE, Kang SY, Lee JS, Lee J, Kim MS, Yea DA, Ma HI (2024) Comparative olfactory profiles in Parkinson\u2019s disease and Drug-Induced parkinsonism. J Mov Disord 17:64\u201370","journal-title":"J Mov Disord"},{"key":"10128_CR127","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1093\/chemse\/bjs073","volume":"38","author":"H Lapid","year":"2013","unstructured":"Lapid H, Hummel T (2013) Recording odor-evoked response potentials at the human olfactory epithelium. Chem Senses 38:3\u201317","journal-title":"Chem Senses"},{"key":"10128_CR128","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/nrn3406","volume":"14","author":"HA Lashuel","year":"2013","unstructured":"Lashuel HA, Overk CR, Oueslati A, Masliah E (2013) The many faces of alpha-synuclein: from structure and toxicity to therapeutic target. Nat Rev Neurosci 14:38\u201348","journal-title":"Nat Rev Neurosci"},{"key":"10128_CR129","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.parkreldis.2016.09.023","volume":"33","author":"M Lawton","year":"2016","unstructured":"Lawton M, Hu MT, Baig F, Ruffmann C, Barron E, Swallow DM, Malek N, Grosset KA, Bajaj N, Barker RA, Williams N, Burn DJ, Foltynie T, Morris HR, Wood NW, May MT, Grosset DG, Ben-Shlomo Y (2016) Equating scores of the university of Pennsylvania smell identification test and sniffin\u2019 sticks test in patients with Parkinson\u2019s disease. Parkinsonism Relat Disord 33:96\u2013101","journal-title":"Parkinsonism Relat Disord"},{"key":"10128_CR130","doi-asserted-by":"publisher","first-page":"6963","DOI":"10.1523\/JNEUROSCI.6513-10.2011","volume":"31","author":"KW Lee","year":"2011","unstructured":"Lee KW, Chen W, Junn E, Im JY, Grosso H, Sonsalla PK, Feng X, Ray N, Fernandez JR, Chao Y, Masliah E, Voronkov M, Braithwaite SP, Stock JB, Mouradian MM (2011) Enhanced phosphatase activity attenuates alpha-synucleinopathy in a mouse model. J Neurosci 31:6963\u20136971","journal-title":"J Neurosci"},{"key":"10128_CR131","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/ana.23894","volume":"73","author":"S Lesage","year":"2013","unstructured":"Lesage S, Anheim M, Letournel F, Bousset L, Honore A, Rozas N, Pieri L, Madiona K, Durr A, Melki R, Verny C, Brice A, French Parkinson\u2019s Disease Genetics Study G (2013) G51D alpha-synuclein mutation causes a novel parkinsonian-pyramidal syndrome. Ann Neurol 73:459\u2013471","journal-title":"Ann Neurol"},{"key":"10128_CR132","doi-asserted-by":"publisher","first-page":"104021","DOI":"10.1016\/j.ebiom.2022.104021","volume":"80","author":"J Levin","year":"2022","unstructured":"Levin J, Sing N, Melbourne S, Morgan A, Mariner C, Spillantini MG, Wegrzynowicz M, Dalley JW, Langer S, Ryazanov S, Leonov A, Griesinger C, Schmidt F, Weckbecker D, Prager K, Matthias T, Giese A (2022) Safety, tolerability and pharmacokinetics of the oligomer modulator anle138b with exposure levels sufficient for therapeutic efficacy in a murine Parkinson model: A randomised, double-blind, placebo-controlled phase 1a trial. EBioMedicine 80:104021","journal-title":"EBioMedicine"},{"key":"10128_CR134","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.bbr.2015.07.058","volume":"294","author":"Y Liu","year":"2015","unstructured":"Liu Y, Sun JD, Song LK, Li J, Chu SF, Yuan YH, Chen NH (2015) Environment-contact administration of rotenone: A new rodent model of Parkinson\u2019s disease. Behav Brain Res 294:149\u2013161","journal-title":"Behav Brain Res"},{"key":"10128_CR133","doi-asserted-by":"crossref","unstructured":"Liu X, Balaraman K, Lynch CC, Hebron M, Shah PK, Hu S, Stevenson M, Wolf C, Moussa C (2022) Inhibition of Ubiquitin-Specific Protease-13 improves behavioral performance in Alpha-Synuclein expressing mice. Int J Mol Sci 23(15):8131","DOI":"10.3390\/ijms23158131"},{"key":"10128_CR135","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.neubiorev.2021.02.024","volume":"125","author":"AM Lyons-Warren","year":"2021","unstructured":"Lyons-Warren AM, Herman I, Hunt PJ, Arenkiel BR (2021) A systematic-review of olfactory deficits in neurodevelopmental disorders: from mouse to human. Neurosci Biobehav Rev 125:110\u2013121","journal-title":"Neurosci Biobehav Rev"},{"key":"10128_CR136","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.neuron.2014.10.019","volume":"84","author":"S Maday","year":"2014","unstructured":"Maday S, Twelvetrees AE, Moughamian AJ, Holzbaur EL (2014) Axonal transport: cargo-specific mechanisms of motility and regulation. Neuron 84:292\u2013309","journal-title":"Neuron"},{"key":"10128_CR137","doi-asserted-by":"publisher","first-page":"1180868","DOI":"10.3389\/fnins.2023.1180868","volume":"17","author":"S Mahajan","year":"2023","unstructured":"Mahajan S, Sen D, Sunil A, Srikanth P, Marathe SD, Shaw K, Sahare M, Galande S, Abraham NM (2023) Knockout of angiotensin converting enzyme-2 receptor leads to morphological aberrations in rodent olfactory centers and dysfunctions associated with sense of smell. Front Neurosci 17:1180868","journal-title":"Front Neurosci"},{"key":"10128_CR138","unstructured":"Mahajan S, Tamboli S, Das S, Bhattacharjee AS, Pardasani M, Srikanth P, Marathe SD, Adlakha A, Ranjan L, Pandey S, Abraham NM, bioRxiv (2024) 2024.2008.2028.610087"},{"key":"10128_CR139","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3389\/fnins.2018.00225","volume":"12","author":"A Maharjan","year":"2018","unstructured":"Maharjan A, Wang E, Peng M, Cakmak YO (2018) Improvement of olfactory function with high frequency Non-invasive auricular electrostimulation in healthy humans. Front Neurosci 12:225","journal-title":"Front Neurosci"},{"key":"10128_CR140","doi-asserted-by":"publisher","first-page":"690293","DOI":"10.3389\/fnagi.2021.690293","volume":"13","author":"NO Manzanza","year":"2021","unstructured":"Manzanza NO, Sedlackova L, Kalaria RN (2021) Alpha-Synuclein Post-translational modifications: implications for pathogenesis of lewy body disorders. Front Aging Neurosci 13:690293","journal-title":"Front Aging Neurosci"},{"key":"10128_CR141","doi-asserted-by":"crossref","unstructured":"Mao X, Ou MT, Karuppagounder SS, Kam TI, Yin X, Xiong Y, Ge P, Umanah GE, Brahmachari S, Shin JH, Kang HC, Zhang J, Xu J, Chen R, Park H, Andrabi SA, Kang SU, Goncalves RA, Liang Y, Zhang S, Qi C, Lam S, Keiler JA, Tyson J, Kim D, Panicker N, Yun SP, Workman CJ, Vignali DA, Dawson VL, Ko HS, Dawson TM (2016) Pathological alpha-synuclein transmission initiated by binding lymphocyte-activation gene 3. Science 353(6307):aah3374","DOI":"10.1126\/science.aah3374"},{"key":"10128_CR142","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3389\/fnagi.2019.00023","volume":"11","author":"Z Mao","year":"2019","unstructured":"Mao Z, Ling Z, Pan L, Xu X, Cui Z, Liang S, Yu X (2019) Comparison of efficacy of deep brain stimulation of different targets in Parkinson\u2019s disease: A network Meta-Analysis. Front Aging Neurosci 11:23","journal-title":"Front Aging Neurosci"},{"key":"10128_CR143","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1523\/JNEUROSCI.1526-22.2022","volume":"43","author":"E Martin-Lopez","year":"2023","unstructured":"Martin-Lopez E, Vidyadhara DJ, Liberia T, Meller SJ, Harmon LE, Hsu RM, Spence N, Brennan B, Han K, Yucel B, Chandra SS, Greer CA (2023) alpha-Synuclein pathology and reduced neurogenesis in the olfactory system affect olfaction in a mouse model of Parkinson\u2019s disease. J Neurosci 43:1051\u20131071","journal-title":"J Neurosci"},{"key":"10128_CR144","doi-asserted-by":"crossref","unstructured":"Maset A, Albanesi M, di Soccio A, Canova M, Dal Maschio M, Lodovichi C (2021) Aberrant patterns of Sensory-Evoked activity in the olfactory bulb of LRRK2 knockout mice. Cells 10(11):3212","DOI":"10.3390\/cells10113212"},{"key":"10128_CR146","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1093\/brain\/awt037","volume":"136","author":"M Masuda-Suzukake","year":"2013","unstructured":"Masuda-Suzukake M, Nonaka T, Hosokawa M, Oikawa T, Arai T, Akiyama H, Mann DM, Hasegawa M (2013) Prion-like spreading of pathological alpha-synuclein in brain. Brain 136:1128\u20131138","journal-title":"Brain"},{"key":"10128_CR145","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s40478-014-0088-8","volume":"2","author":"M Masuda-Suzukake","year":"2014","unstructured":"Masuda-Suzukake M, Nonaka T, Hosokawa M, Kubo M, Shimozawa A, Akiyama H, Hasegawa M (2014) Pathological alpha-synuclein propagates through neural networks. Acta Neuropathol Commun 2:88","journal-title":"Acta Neuropathol Commun"},{"key":"10128_CR147","doi-asserted-by":"publisher","first-page":"647","DOI":"10.4103\/1673-5374.230289","volume":"13","author":"AT Medeiros","year":"2018","unstructured":"Medeiros AT, Bubacco L, Morgan JR (2018) Impacts of increased alpha-synuclein on clathrin-mediated endocytosis at synapses: implications for neurodegenerative diseases. Neural Regen Res 13:647\u2013648","journal-title":"Neural Regen Res"},{"key":"10128_CR148","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.bbapap.2019.03.001","volume":"1867","author":"S Mehra","year":"2019","unstructured":"Mehra S, Sahay S, Maji SK (2019) alpha-Synuclein misfolding and aggregation: implications in Parkinson\u2019s disease pathogenesis. Biochim Biophys Acta Proteins Proteom 1867:890\u2013908","journal-title":"Biochim Biophys Acta Proteins Proteom"},{"key":"10128_CR149","doi-asserted-by":"publisher","first-page":"852003","DOI":"10.3389\/fneur.2022.852003","volume":"13","author":"S Menon","year":"2022","unstructured":"Menon S, Armstrong S, Hamzeh A, Visanji NP, Sardi SP, Tandon A (2022) Alpha-Synuclein targeting therapeutics for Parkinson\u2019s disease and related synucleinopathies. Front Neurol 13:852003","journal-title":"Front Neurol"},{"key":"10128_CR150","doi-asserted-by":"publisher","first-page":"104623","DOI":"10.1016\/j.nbd.2019.104623","volume":"134","author":"C Mezias","year":"2020","unstructured":"Mezias C, Rey N, Brundin P, Raj A (2020) Neural connectivity predicts spreading of alpha-synuclein pathology in fibril-injected mouse models: involvement of retrograde and anterograde axonal propagation. Neurobiol Dis 134:104623","journal-title":"Neurobiol Dis"},{"key":"10128_CR151","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.nbd.2015.12.018","volume":"88","author":"DE Mor","year":"2016","unstructured":"Mor DE, Ugras SE, Daniels MJ, Ischiropoulos H (2016) Dynamic structural flexibility of alpha-synuclein. Neurobiol Dis 88:66\u201374","journal-title":"Neurobiol Dis"},{"key":"10128_CR152","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s41232-023-00269-3","volume":"43","author":"A Morizane","year":"2023","unstructured":"Morizane A (2023) Cell therapy for Parkinson\u2019s disease with induced pluripotent stem cells. Inflamm Regen 43:16","journal-title":"Inflamm Regen"},{"key":"10128_CR153","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0140-6736(23)01478-2","volume":"403","author":"HR Morris","year":"2024","unstructured":"Morris HR, Spillantini MG, Sue CM, Williams-Gray CH (2024) The pathogenesis of Parkinson\u2019s disease. Lancet 403:293\u2013304","journal-title":"Lancet"},{"key":"10128_CR154","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1634\/stemcells.2008-0074","volume":"26","author":"W Murrell","year":"2008","unstructured":"Murrell W, Wetzig A, Donnellan M, F\u00e9ron F, Burne T, Meedeniya A, Kesby J, Bianco J, Perry C, Silburn P, Mackay-Sim A (2008) Olfactory mucosa is a potential source for autologous stem cell therapy for Parkinson\u2019s disease. Stem Cells 26:2183\u20132192","journal-title":"Stem Cells"},{"key":"10128_CR155","first-page":"422","volume":"21","author":"M Mustapha","year":"2021","unstructured":"Mustapha M, Mat Taib CN (2021) MPTP-induced mouse model of Parkinson\u2019s disease: A promising direction of therapeutic strategies. Bosn J Basic Med Sci 21:422\u2013433","journal-title":"Bosn J Basic Med Sci"},{"key":"10128_CR156","doi-asserted-by":"publisher","first-page":"4193","DOI":"10.1007\/s10072-022-05952-w","volume":"43","author":"F Nabizadeh","year":"2022","unstructured":"Nabizadeh F, Pirahesh K, Khalili E (2022) Olfactory dysfunction is associated with motor function only in tremor-dominant Parkinson\u2019s disease. Neurol Sci 43:4193\u20134201","journal-title":"Neurol Sci"},{"key":"10128_CR157","doi-asserted-by":"crossref","unstructured":"Norwood JN, Zhang Q, Card D, Craine A, Ryan TM, Drew PJ (2019) Anatomical basis and physiological role of cerebrospinal fluid transport through the murine cribriform plate. Elife 8:e44278","DOI":"10.7554\/eLife.44278"},{"key":"10128_CR158","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/wjo2.175","volume":"10","author":"S Pandey","year":"2024","unstructured":"Pandey S, Bapat V, Abraham JN, Abraham NM (2024) Long COVID: from olfactory dysfunctions to viral parkinsonism. World J Otorhinolaryngol Head Neck Surg 10(2):137\u2013147. https:\/\/doi.org\/10.1002\/wjo2.175","journal-title":"World J Otorhinolaryngol Head Neck Surg"},{"key":"10128_CR159","doi-asserted-by":"publisher","DOI":"10.5772\/intechopen.108573","volume-title":"COVID-19 pandemic, mental health and neuroscience","author":"M Pardasani","year":"2022","unstructured":"Pardasani M, Abraham NM (2022) Neurotropic SARS-CoV-2: causalities and realities. In: Sara P, Berend O (eds) COVID-19 pandemic, mental health and neuroscience. IntechOpen, Rijeka. Ch. 1. https:\/\/doi.org\/10.5772\/intechopen.108573"},{"key":"10128_CR160","doi-asserted-by":"crossref","unstructured":"Pardasani M, Marathe SD, Purnapatre MM, Dalvi U, Abraham NM (2021) Multimodal learning of pheromone locations. FASEB J 35(9):e21836","DOI":"10.1096\/fj.202100167R"},{"key":"10128_CR161","doi-asserted-by":"crossref","unstructured":"Pardasani M, Ramakrishnan AM, Mahajan S, Kantroo M, McGowan E, Das S, Srikanth P, Pandey S, Abraham NM (2023) Perceptual learning deficits mediated by somatostatin releasing inhibitory interneurons of olfactory bulb in an early life stress mouse model. Mol Psychiatry 28(11):4693\u20134706","DOI":"10.1038\/s41380-023-02244-3"},{"key":"10128_CR162","volume-title":"An essay on the shaking palsy","author":"J Parkinson","year":"1817","unstructured":"Parkinson J (1817) An essay on the shaking palsy. Whittingham and Rowland, Goswell Street"},{"key":"10128_CR163","doi-asserted-by":"publisher","first-page":"2180e2181","DOI":"10.1016\/j.neurobiolaging.2014.03.024","volume":"35","author":"P Pasanen","year":"2014","unstructured":"Pasanen P, Myllykangas L, Siitonen M, Raunio A, Kaakkola S, Lyytinen J, Tienari PJ, Poyhonen M, Paetau A (2014) Novel alpha-synuclein mutation A53E associated with atypical multiple system atrophy and Parkinson\u2019s disease-type pathology. Neurobiol Aging 35:2180e2181\u20132180e2185","journal-title":"Neurobiol Aging"},{"key":"10128_CR164","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/alr.21669","volume":"6","author":"K Pekala","year":"2016","unstructured":"Pekala K, Chandra RK, Turner JH (2016) Efficacy of olfactory training in patients with olfactory loss: a systematic review and meta-analysis. Int Forum Allergy Rhinol 6:299\u2013307","journal-title":"Int Forum Allergy Rhinol"},{"key":"10128_CR165","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.physbeh.2017.04.006","volume":"177","author":"R Pellegrino","year":"2017","unstructured":"Pellegrino R, Sinding C, de Wijk RA, Hummel T (2017) Habituation and adaptation to odors in humans. Physiol Behav 177:13\u201319","journal-title":"Physiol Behav"},{"key":"10128_CR166","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.4103\/1673-5374.284993","volume":"15","author":"S Pena-Diaz","year":"2020","unstructured":"Pena-Diaz S, Pujols J, Ventura S (2020) Small molecules to prevent the neurodegeneration caused by alpha-synuclein aggregation. Neural Regen Res 15:2260\u20132261","journal-title":"Neural Regen Res"},{"key":"10128_CR167","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.nbd.2017.07.018","volume":"109","author":"C Peng","year":"2018","unstructured":"Peng C, Gathagan RJ, Lee VM (2018) Distinct alpha-Synuclein strains and implications for heterogeneity among alpha-Synucleinopathies. Neurobiol Dis 109:209\u2013218","journal-title":"Neurobiol Dis"},{"key":"10128_CR168","doi-asserted-by":"crossref","unstructured":"Philippens I, B\u00f6sz\u00f6rm\u00e9nyi KP, Wubben JAM, Fagrouch ZC, van Driel N, Mayenburg AQ, Lozovagia D, Roos E, Schurink B, Bugiani M, Bontrop RE, Middeldorp J, Bogers WM, de Geus-Oei LF, Langermans JAM, Verschoor EJ, Stammes MA, Verstrepen BE (2022) Brain inflammation and intracellular \u03b1-Synuclein aggregates in macaques after SARS-CoV-2 infection. Viruses 14(4):776","DOI":"10.3390\/v14040776"},{"key":"10128_CR169","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.bbr.2017.02.010","volume":"325","author":"KA Phillips","year":"2017","unstructured":"Phillips KA, Ross CN, Spross J, Cheng CJ, Izquierdo A, Biju KC, Chen C, Li S, Tardif SD (2017) Behavioral phenotypes associated with MPTP induction of partial lesions in common marmosets (Callithrix jacchus). Behav Brain Res 325:51\u201362","journal-title":"Behav Brain Res"},{"key":"10128_CR170","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12987-024-00542-8","volume":"21","author":"G Pierobon Mays","year":"2024","unstructured":"Pierobon Mays G, Hett K, Eisma J, McKnight CD, Elenberger J, Song AK, Considine C, Richerson WT, Han C, Stark A, Claassen DO, Donahue MJ (2024) Reduced cerebrospinal fluid motion in patients with Parkinson\u2019s disease revealed by magnetic resonance imaging with low b-value diffusion weighted imaging. Fluids Barriers CNS 21:40","journal-title":"Fluids Barriers CNS"},{"key":"10128_CR171","doi-asserted-by":"publisher","first-page":"17013","DOI":"10.1038\/nrdp.2017.13","volume":"3","author":"W Poewe","year":"2017","unstructured":"Poewe W, Seppi K, Tanner CM, Halliday GM, Brundin P, Volkmann J, Schrag AE, Lang AE (2017) Parkinson disease. Nat Rev Dis Primers 3:17013","journal-title":"Nat Rev Dis Primers"},{"key":"10128_CR172","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","volume":"276","author":"MH Polymeropoulos","year":"1997","unstructured":"Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, Pike B, Root H, Rubenstein J, Boyer R, Stenroos ES, Chandrasekharappa S, Athanassiadou A, Papapetropoulos T, Johnson WG, Lazzarini AM, Duvoisin RC, Di Iorio G, Golbe LI, Nussbaum RL (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson\u2019s disease. Science 276:2045\u20132047","journal-title":"Science"},{"key":"10128_CR173","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1007\/s12640-009-9087-0","volume":"17","author":"RD Prediger","year":"2010","unstructured":"Prediger RD, Aguiar AS Jr., Rojas-Mayorquin AE, Figueiredo CP, Matheus FC, Ginestet L, Chevarin C, Bel ED, Mongeau R, Hamon M, Lanfumey L, Raisman-Vozari R (2010) Single intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57BL\/6 mice models early preclinical phase of Parkinson\u2019s disease. Neurotox Res 17:114\u2013129","journal-title":"Neurotox Res"},{"key":"10128_CR174","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1046\/j.1471-4159.2001.00183.x","volume":"76","author":"S Przedborski","year":"2001","unstructured":"Przedborski S, Jackson-Lewis V, Naini AB, Jakowec M, Petzinger G, Miller R, Akram M (2001) The parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a technical review of its utility and safety. J Neurochem 76:1265\u20131274","journal-title":"J Neurochem"},{"key":"10128_CR175","doi-asserted-by":"publisher","first-page":"10481","DOI":"10.1073\/pnas.1804198115","volume":"115","author":"J Pujols","year":"2018","unstructured":"Pujols J, Pena-Diaz S, Lazaro DF, Peccati F, Pinheiro F, Gonzalez D, Carija A, Navarro S, Conde-Gimenez M, Garcia J, Guardiola S, Giralt E, Salvatella X, Sancho J, Sodupe M, Outeiro TF, Dalfo E, Ventura S (2018) Small molecule inhibits alpha-synuclein aggregation, disrupts amyloid fibrils, and prevents degeneration of dopaminergic neurons. Proc Natl Acad Sci U S A 115:10481\u201310486","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10128_CR176","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/s41586-020-2388-4","volume":"582","author":"H Qian","year":"2020","unstructured":"Qian H, Kang X, Hu J, Zhang D, Liang Z, Meng F, Zhang X, Xue Y, Maimon R, Dowdy SF, Devaraj NK, Zhou Z, Mobley WC, Cleveland DW, Fu XD (2020) Reversing a model of Parkinson\u2019s disease with in situ converted nigral neurons. Nature 582:550\u2013556","journal-title":"Nature"},{"key":"10128_CR177","doi-asserted-by":"publisher","first-page":"101752","DOI":"10.1016\/j.jchemneu.2020.101752","volume":"104","author":"SN Rai","year":"2020","unstructured":"Rai SN, Singh P (2020) Advancement in the modelling and therapeutics of Parkinson\u2019s disease. J Chem Neuroanat 104:101752","journal-title":"J Chem Neuroanat"},{"key":"10128_CR178","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1007\/s00405-015-3682-x","volume":"273","author":"J Reden","year":"2016","unstructured":"Reden J, Draf C, Frank RA, Hummel T (2016) Comparison of clinical tests of olfactory function. Eur Arch Otorhinolaryngol 273:927\u2013931","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10128_CR179","doi-asserted-by":"publisher","first-page":"101965","DOI":"10.1016\/j.jchemneu.2021.101965","volume":"115","author":"HS Rethinavel","year":"2021","unstructured":"Rethinavel HS, Ravichandran S, Radhakrishnan RK, Kandasamy M (2021) COVID-19 and Parkinson\u2019s disease: defects in neurogenesis as the potential cause of olfactory system impairments and anosmia. J Chem Neuroanat 115:101965","journal-title":"J Chem Neuroanat"},{"key":"10128_CR182","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s00401-013-1160-3","volume":"126","author":"NL Rey","year":"2013","unstructured":"Rey NL, Petit GH, Bousset L, Melki R, Brundin P (2013) Transfer of human \u03b1-synuclein from the olfactory bulb to interconnected brain regions in mice. Acta Neuropathol 126:555\u2013573","journal-title":"Acta Neuropathol"},{"key":"10128_CR180","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/nan.12299","volume":"42","author":"NL Rey","year":"2016","unstructured":"Rey NL, George S, Brundin P (2016a) Review: spreading the word: precise animal models and validated methods are vital when evaluating prion-like behaviour of alpha-synuclein. Neuropathol Appl Neurobiol 42:51\u201376","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10128_CR183","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1084\/jem.20160368","volume":"213","author":"NL Rey","year":"2016","unstructured":"Rey NL, Steiner JA, Maroof N, Luk KC, Madaj Z, Trojanowski JQ, Lee VM, Brundin P (2016b) Widespread transneuronal propagation of \u03b1-synucleinopathy triggered in olfactory bulb mimics prodromal Parkinson\u2019s disease. J Exp Med 213:1759\u20131778","journal-title":"J Exp Med"},{"key":"10128_CR181","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s00401-017-1792-9","volume":"135","author":"NL Rey","year":"2018","unstructured":"Rey NL, George S, Steiner JA, Madaj Z, Luk KC, Trojanowski JQ, Lee VM, Brundin P (2018a) Spread of aggregates after olfactory bulb injection of alpha-synuclein fibrils is associated with early neuronal loss and is reduced long term. Acta Neuropathol 135:65\u201383","journal-title":"Acta Neuropathol"},{"key":"10128_CR184","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.nbd.2016.12.013","volume":"109","author":"NL Rey","year":"2018","unstructured":"Rey NL, Wesson DW, Brundin P (2018b) The olfactory bulb as the entry site for prion-like propagation in neurodegenerative diseases. Neurobiol Dis 109:226\u2013248","journal-title":"Neurobiol Dis"},{"key":"10128_CR185","doi-asserted-by":"publisher","first-page":"e114216","DOI":"10.1371\/journal.pone.0114216","volume":"9","author":"D Rial","year":"2014","unstructured":"Rial D, Castro AA, Machado N, Garcao P, Goncalves FQ, Silva HB, Tome AR, Kofalvi A, Corti O, Raisman-Vozari R, Cunha RA, Prediger RD (2014) Behavioral phenotyping of Parkin-deficient mice: looking for early preclinical features of Parkinson\u2019s disease. PLoS ONE 9:e114216","journal-title":"PLoS ONE"},{"key":"10128_CR186","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/S1474-4422(18)30355-7","volume":"17","author":"WA Rocca","year":"2018","unstructured":"Rocca WA (2018) The burden of Parkinson\u2019s disease: a worldwide perspective. Lancet Neurol 17:928\u2013929","journal-title":"Lancet Neurol"},{"key":"10128_CR187","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.nbd.2017.04.004","volume":"109","author":"EM Rocha","year":"2018","unstructured":"Rocha EM, De Miranda B, Sanders LH (2018) Alpha-synuclein: pathology, mitochondrial dysfunction and neuroinflammation in Parkinson\u2019s disease. Neurobiol Dis 109:249\u2013257","journal-title":"Neurobiol Dis"},{"key":"10128_CR188","doi-asserted-by":"publisher","first-page":"13176","DOI":"10.1073\/pnas.1704351114","volume":"114","author":"R Rott","year":"2017","unstructured":"Rott R, Szargel R, Shani V, Hamza H, Savyon M, Abd Elghani F, Bandopadhyay R, Engelender S (2017) SUMOylation and ubiquitination reciprocally regulate alpha-synuclein degradation and pathological aggregation. Proc Natl Acad Sci U S A 114:13176\u201313181","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10128_CR189","doi-asserted-by":"publisher","first-page":"1351721","DOI":"10.3389\/fnins.2024.1351721","volume":"18","author":"R Roy","year":"2024","unstructured":"Roy R, D\u2019Angiulli A (2024) Air pollution and neurological diseases, current state highlights. Front Neurosci 18:1351721","journal-title":"Front Neurosci"},{"key":"10128_CR190","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.anorl.2015.08.004","volume":"133","author":"C Rumeau","year":"2016","unstructured":"Rumeau C, Nguyen DT, Jankowski R (2016) How to assess olfactory performance with the sniffin\u2019 sticks test((R)). Eur Ann Otorhinolaryngol Head Neck Dis 133:203\u2013206","journal-title":"Eur Ann Otorhinolaryngol Head Neck Dis"},{"key":"10128_CR191","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jocn.2019.07.055","volume":"68","author":"O Saatci","year":"2019","unstructured":"Saatci O, Yilmaz NH, Zirh A, Yulug B (2019) The therapeutic effect of deep brain stimulation on olfactory functions and clinical scores in Parkinson\u2019s disease. J Clin Neurosci 68:55\u201361","journal-title":"J Clin Neurosci"},{"key":"10128_CR192","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1242\/jcs.00967","volume":"117","author":"AR Saha","year":"2004","unstructured":"Saha AR, Hill J, Utton MA, Asuni AA, Ackerley S, Grierson AJ, Miller CC, Davies AM, Buchman VL, Anderton BH, Hanger DP (2004) Parkinson\u2019s disease alpha-synuclein mutations exhibit defective axonal transport in cultured neurons. J Cell Sci 117:1017\u20131024","journal-title":"J Cell Sci"},{"key":"10128_CR193","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.jconrel.2023.04.021","volume":"358","author":"P Saha","year":"2023","unstructured":"Saha P, Kathuria H, Pandey MM (2023) Intranasal nanotherapeutics for brain targeting and clinical studies in Parkinson\u2019s disease. J Control Release 358:293\u2013318","journal-title":"J Control Release"},{"key":"10128_CR194","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/mds.26463","volume":"31","author":"Y Saito","year":"2016","unstructured":"Saito Y, Shioya A, Sano T, Sumikura H, Murata M, Murayama S (2016) Lewy body pathology involves the olfactory cells in Parkinson\u2019s disease and related disorders. Mov Disord 31:135\u2013138","journal-title":"Mov Disord"},{"key":"10128_CR195","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.neuro.2015.10.006","volume":"51","author":"H Sasajima","year":"2015","unstructured":"Sasajima H, Miyazono S, Noguchi T, Kashiwayanagi M (2015) Intranasal administration of rotenone in mice attenuated olfactory functions through the lesion of dopaminergic neurons in the olfactory bulb. Neurotoxicology 51:106\u2013115","journal-title":"Neurotoxicology"},{"key":"10128_CR196","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1248\/bpb.b16-00654","volume":"40","author":"H Sasajima","year":"2017","unstructured":"Sasajima H, Miyazono S, Noguchi T, Kashiwayanagi M (2017) Intranasal administration of rotenone to mice induces dopaminergic neurite degeneration of dopaminergic neurons in the substantia Nigra. Biol Pharm Bull 40:108\u2013112","journal-title":"Biol Pharm Bull"},{"key":"10128_CR197","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3389\/fnagi.2020.00167","volume":"12","author":"M Savyon","year":"2020","unstructured":"Savyon M, Engelender S (2020) SUMOylation in alpha-synuclein homeostasis and pathology. Front Aging Neurosci 12:167","journal-title":"Front Aging Neurosci"},{"issue":"Suppl 1","key":"10128_CR198","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1016\/S1353-8020(11)70006-2","volume":"18","author":"A Schneeberger","year":"2012","unstructured":"Schneeberger A, Mandler M, Mattner F, Schmidt W (2012) Vaccination for Parkinson\u2019s disease. Parkinsonism Relat Disord 18(Suppl 1):S11\u201313","journal-title":"Parkinsonism Relat Disord"},{"key":"10128_CR199","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1001\/jamaneurol.2022.3902","volume":"80","author":"A Schrag","year":"2023","unstructured":"Schrag A, Bohlken J, Dammertz L, Teipel S, Hermann W, Akmatov MK, Batzing J, Holstiege J (2023) Widening the spectrum of risk factors, comorbidities, and prodromal features of Parkinson disease. JAMA Neurol 80:161\u2013171","journal-title":"JAMA Neurol"},{"key":"10128_CR200","doi-asserted-by":"publisher","first-page":"104760","DOI":"10.1016\/j.nbd.2020.104760","volume":"137","author":"AD Schwab","year":"2020","unstructured":"Schwab AD, Thurston MJ, Machhi J, Olson KE, Namminga KL, Gendelman HE, Mosley RL (2020) Immunotherapy for Parkinson\u2019s disease. Neurobiol Dis 137:104760","journal-title":"Neurobiol Dis"},{"key":"10128_CR201","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1056\/NEJMoa1915872","volume":"382","author":"JS Schweitzer","year":"2020","unstructured":"Schweitzer JS, Song B, Herrington TM, Park TY, Lee N, Ko S, Jeon J, Cha Y, Kim K, Li Q, Henchcliffe C, Kaplitt M, Neff C, Rapalino O, Seo H, Lee IH, Kim J, Kim T, Petsko GA, Ritz J, Cohen BM, Kong SW, Leblanc P, Carter BS, Kim KS (2020) Personalized iPSC-Derived dopamine progenitor cells for Parkinson\u2019s disease. N Engl J Med 382:1926\u20131932","journal-title":"N Engl J Med"},{"key":"10128_CR202","doi-asserted-by":"publisher","unstructured":"Sharma G, Wadhwa K, Kumar S, Singh G, Pahwa R (2025) Revolutionizing Parkinson\u2019s treatment: harnessing the potential of intranasal nanoemulsions for targeted therapy. Drug Deliv Transl Res. https:\/\/doi.org\/10.1007\/s13346-024-01770-z","DOI":"10.1007\/s13346-024-01770-z"},{"key":"10128_CR203","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.bpj.2020.12.031","volume":"120","author":"LJ Shearer","year":"2021","unstructured":"Shearer LJ, Petersen NO, Woodside MT (2021) Internalization of alpha-synuclein oligomers into SH-SY5Y cells. Biophys J 120:877\u2013885","journal-title":"Biophys J"},{"key":"10128_CR204","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1126\/science.1090278","volume":"302","author":"AB Singleton","year":"2003","unstructured":"Singleton AB, Farrer M, Johnson J, Singleton A, Hague S, Kachergus J, Hulihan M, Peuralinna T, Dutra A, Nussbaum R, Lincoln S, Crawley A, Hanson M, Maraganore D, Adler C, Cookson MR, Muenter M, Baptista M, Miller D, Blancato J, Hardy J, Gwinn-Hardy K (2003) alpha-Synuclein locus triplication causes Parkinson\u2019s disease. Science 302:841","journal-title":"Science"},{"key":"10128_CR205","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.neuron.2005.07.022","volume":"47","author":"DM Small","year":"2005","unstructured":"Small DM, Gerber JC, Mak YE, Hummel T (2005) Differential neural responses evoked by orthonasal versus retronasal odorant perception in humans. Neuron 47:593\u2013605","journal-title":"Neuron"},{"key":"10128_CR206","doi-asserted-by":"crossref","unstructured":"Solla P, Masala C, Ercoli T, Orofino G, Loy F, Pinna I, Fadda L, Defazio G (2022) Olfactory impairment in Parkinson\u2019s disease patients with tremor dominant subtype compared to those with akinetic rigid dominant subtype: a pilot study. Brain Sci 12(2):196","DOI":"10.3390\/brainsci12020196"},{"key":"10128_CR207","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/42166","volume":"388","author":"MG Spillantini","year":"1997","unstructured":"Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M (1997) Alpha-synuclein in lewy bodies. Nature 388:839\u2013840","journal-title":"Nature"},{"key":"10128_CR208","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.tibs.2018.11.005","volume":"44","author":"AD Stephens","year":"2019","unstructured":"Stephens AD, Zacharopoulou M, Kaminski Schierle GS (2019) The cellular environment affects monomeric \u03b1-synuclein structure. Trends Biochem Sci 44:453\u2013466","journal-title":"Trends Biochem Sci"},{"key":"10128_CR209","doi-asserted-by":"publisher","first-page":"2820","DOI":"10.1038\/s41467-020-16564-3","volume":"11","author":"AD Stephens","year":"2020","unstructured":"Stephens AD, Zacharopoulou M, Moons R, Fusco G, Seetaloo N, Chiki A, Woodhams PJ, Mela I, Lashuel HA, Phillips JJ, De Simone A, Sobott F, Schierle GSK (2020) Extent of N-terminus exposure of monomeric alpha-synuclein determines its aggregation propensity. Nat Commun 11:2820","journal-title":"Nat Commun"},{"key":"10128_CR210","doi-asserted-by":"publisher","first-page":"646956","DOI":"10.3389\/fnins.2021.646956","volume":"15","author":"B Su","year":"2021","unstructured":"Su B, Bleier B, Wei Y, Wu D (2021) Clinical implications of psychophysical olfactory testing: assessment, diagnosis, and treatment outcome. Front Neurosci 15:646956","journal-title":"Front Neurosci"},{"key":"10128_CR211","doi-asserted-by":"crossref","unstructured":"Sunny LP, Srikanth P, Sunitha AK, Tembulkar N, Abraham JN (2022) Tryptophan-cardanol fluorescent nanoparticles inhibit alpha-synuclein aggregation and disrupt amyloid fibrils. J Pept Sci 28, e3374","DOI":"10.1002\/psc.3374"},{"key":"10128_CR212","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.reth.2020.06.002","volume":"13","author":"J Takahashi","year":"2020","unstructured":"Takahashi J (2020) iPS cell-based therapy for Parkinson\u2019s disease: A Kyoto trial. Regen Ther 13:18\u201322","journal-title":"Regen Ther"},{"key":"10128_CR213","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/s41582-020-0344-4","volume":"16","author":"EK Tan","year":"2020","unstructured":"Tan EK, Chao YX, West A, Chan LL, Poewe W, Jankovic J (2020) Parkinson disease and the immune system - associations, mechanisms and therapeutics. Nat Rev Neurol 16:303\u2013318","journal-title":"Nat Rev Neurol"},{"key":"10128_CR214","doi-asserted-by":"publisher","first-page":"106514","DOI":"10.1016\/j.nbd.2024.106514","volume":"196","author":"C Tremblay","year":"2024","unstructured":"Tremblay C, Aslam S, Walker JE, Lorenzini I, Intorcia AJ, Arce RA, Choudhury P, Adler CH, Shill HA, Driver-Dunckley E, Mehta S, Piras IS, Belden CM, Atri A, Beach TG, Serrano GE (2024) RNA sequencing of olfactory bulb in Parkinson\u2019s disease reveals gene alterations associated with olfactory dysfunction. Neurobiol Dis 196:106514","journal-title":"Neurobiol Dis"},{"key":"10128_CR215","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1523\/JNEUROSCI.1871-20.2020","volume":"41","author":"D Trudler","year":"2021","unstructured":"Trudler D, Sanz-Blasco S, Eisele YS, Ghatak S, Bodhinathan K, Akhtar MW, Lynch WP, Pina-Crespo JC, Talantova M, Kelly JW, Lipton SA (2021) alpha-Synuclein oligomers induce glutamate release from astrocytes and excessive extrasynaptic NMDAR activity in neurons, thus contributing to synapse loss. J Neurosci 41:2264\u20132273","journal-title":"J Neurosci"},{"key":"10128_CR216","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1002\/mds.28512","volume":"36","author":"N Uemura","year":"2021","unstructured":"Uemura N, Ueda J, Yoshihara T, Ikuno M, Uemura MT, Yamakado H, Asano M, Trojanowski JQ, Takahashi R (2021) Alpha-synuclein spread from olfactory bulb causes hyposmia, anxiety, and memory loss in BAC-SNCA mice. Mov Disord 36:2036\u20132047","journal-title":"Mov Disord"},{"key":"10128_CR217","first-page":"421","volume":"5","author":"U Ungerstedt","year":"1974","unstructured":"Ungerstedt U, Ljungberg T, Steg G (1974) Behavioral, physiological, and neurochemical changes after 6-hydroxydopamine-induced degeneration of the nigro-striatal dopamine neurons. Adv Neurol 5:421\u2013426","journal-title":"Adv Neurol"},{"key":"10128_CR218","doi-asserted-by":"publisher","first-page":"4645","DOI":"10.1242\/jcs.02558","volume":"118","author":"MA Utton","year":"2005","unstructured":"Utton MA, Noble WJ, Hill JE, Anderton BH, Hanger DP (2005) Molecular motors implicated in the axonal transport of Tau and alpha-synuclein. J Cell Sci 118:4645\u20134654","journal-title":"J Cell Sci"},{"key":"10128_CR219","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1097\/WNR.0000000000000218","volume":"25","author":"P Valle-Leija","year":"2014","unstructured":"Valle-Leija P, Drucker-Colin R (2014) Unilateral olfactory deficit in a Hemiparkinson\u2019s disease mouse model. NeuroReport 25:948\u2013953","journal-title":"NeuroReport"},{"key":"10128_CR220","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1038\/s41467-020-16046-6","volume":"11","author":"S Valverde","year":"2020","unstructured":"Valverde S, Vandecasteele M, Piette C, Derousseaux W, Gangarossa G, Aristieta Arbelaiz A, Touboul J, Degos B, Venance L (2020) Deep brain stimulation-guided optogenetic rescue of parkinsonian symptoms. Nat Commun 11:2388","journal-title":"Nat Commun"},{"key":"10128_CR221","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s40136-022-00433-2","volume":"10","author":"V Van Regemorter","year":"2022","unstructured":"Van Regemorter V, Rombaux P, Dricot L, Kupers R, Gregoire A, Hox V, Huart C (2022) Functional imaging in olfactory disorders. Curr Otorhinolaryngol Rep 10:421\u2013426","journal-title":"Curr Otorhinolaryngol Rep"},{"key":"10128_CR222","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.parkreldis.2021.09.007","volume":"91","author":"S Venezia","year":"2021","unstructured":"Venezia S, Kaufmann WA, Wenning GK, Stefanova N (2021) Toll-like receptor 4 deficiency facilitates alpha-synuclein propagation and neurodegeneration in a mouse model of prodromal Parkinson\u2019s disease. Parkinsonism Relat Disord 91:59\u201365","journal-title":"Parkinsonism Relat Disord"},{"key":"10128_CR223","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.neuron.2011.08.033","volume":"72","author":"LA Volpicelli-Daley","year":"2011","unstructured":"Volpicelli-Daley LA, Luk KC, Patel TP, Tanik SA, Riddle DM, Stieber A, Meaney DF, Trojanowski JQ, Lee VM (2011) Exogenous alpha-synuclein fibrils induce lewy body pathology leading to synaptic dysfunction and neuron death. Neuron 72:57\u201371","journal-title":"Neuron"},{"key":"10128_CR224","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s10517-017-3958-9","volume":"164","author":"DN Voronkov","year":"2017","unstructured":"Voronkov DN, Kutukova KA, Ivanov MV, Khudoerkov RM (2017) Immunomorphological changes in the olfactory bulbs of rats after intranasal administration of rotenone. Bull Exp Biol Med 164:203\u2013206","journal-title":"Bull Exp Biol Med"},{"key":"10128_CR225","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1007\/s00401-013-1114-9","volume":"125","author":"J Wagner","year":"2013","unstructured":"Wagner J, Ryazanov S, Leonov A, Levin J, Shi S, Schmidt F, Prix C, Pan-Montojo F, Bertsch U, Mitteregger-Kretzschmar G, Geissen M, Eiden M, Leidel F, Hirschberger T, Deeg AA, Krauth JJ, Zinth W, Tavan P, Pilger J, Zweckstetter M, Frank T, Bahr M, Weishaupt JH, Uhr M, Urlaub H, Teichmann U, Samwer M, Botzel K, Groschup M, Kretzschmar H, Griesinger C, Giese A (2013) Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson\u2019s disease. Acta Neuropathol 125:795\u2013813","journal-title":"Acta Neuropathol"},{"key":"10128_CR226","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1111\/neup.12691","volume":"40","author":"K Wakabayashi","year":"2020","unstructured":"Wakabayashi K (2020) Where and how alpha-synuclein pathology spreads in Parkinson\u2019s disease. Neuropathology 40:415\u2013425","journal-title":"Neuropathology"},{"key":"10128_CR227","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1038\/s41401-022-01039-6","volume":"44","author":"Q Wang","year":"2023","unstructured":"Wang Q, Yao S, Yang ZX, Zhou C, Zhang Y, Zhang Y, Zhang L, Li JT, Xu ZJ, Zhu WL, Zhang NX, Ye Y, Feng LY (2023) Pharmacological characterization of the small molecule 03A10 as an inhibitor of alpha-synuclein aggregation for Parkinson\u2019s disease treatment. Acta Pharmacol Sin 44:1122\u20131134","journal-title":"Acta Pharmacol Sin"},{"key":"10128_CR228","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s40478-024-01873-1","volume":"12","author":"Z Wang","year":"2024","unstructured":"Wang Z, Gilliland T, Kim HJ, Gerasimenko M, Sajewski K, Camacho MV, Bebek G, Chen SG, Gunzler SA, Kong Q (2024) A minimally invasive biomarker for sensitive and accurate diagnosis of Parkinson\u2019s disease. Acta Neuropathol Commun 12:167","journal-title":"Acta Neuropathol Commun"},{"key":"10128_CR229","doi-asserted-by":"crossref","unstructured":"Weir EM, Hannum ME, Reed DR, Joseph PV, Munger SD, Hayes JE, Gerkin RC (2022) The adaptive olfactory measure of threshold (ArOMa-T): a rapid test of olfactory function. Chem Senses 47:bjac036","DOI":"10.1093\/chemse\/bjac036"},{"key":"10128_CR230","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1001\/jamaoto.2019.1728","volume":"145","author":"KL Whitcroft","year":"2019","unstructured":"Whitcroft KL, Hummel T (2019) Clinical diagnosis and current management strategies for olfactory dysfunction: a review. JAMA Otolaryngol Head Neck Surg 145:846\u2013853","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"10128_CR231","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bandc.2016.01.004","volume":"104","author":"TL White","year":"2016","unstructured":"White TL, Sadikot AF, Djordjevic J (2016) Metacognitive knowledge of olfactory dysfunction in Parkinson\u2019s disease. Brain Cogn 104:1\u20136","journal-title":"Brain Cogn"},{"key":"10128_CR232","unstructured":"WHO (2023) Parkinson disease"},{"key":"10128_CR233","doi-asserted-by":"publisher","first-page":"1470171","DOI":"10.3389\/fnmol.2024.1470171","volume":"17","author":"S Wu","year":"2024","unstructured":"Wu S, Schekman RW (2024) Intercellular transmission of alpha-synuclein. Front Mol Neurosci 17:1470171","journal-title":"Front Mol Neurosci"},{"key":"10128_CR234","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1002\/mds.101","volume":"33","author":"K Xhima","year":"2018","unstructured":"Xhima K, Nabbouh F, Hynynen K, Aubert I, Tandon A (2018) Noninvasive delivery of an alpha-synuclein gene silencing vector with magnetic resonance-guided focused ultrasound. Mov Disord 33:1567\u20131579","journal-title":"Mov Disord"},{"key":"10128_CR235","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s12967-023-04012-x","volume":"21","author":"B Xiao","year":"2023","unstructured":"Xiao B, Tan EK (2023) Immunotherapy trials in Parkinson\u2019s disease: challenges. J Transl Med 21:178","journal-title":"J Transl Med"},{"key":"10128_CR236","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s40035-023-00390-w","volume":"12","author":"W Xu","year":"2023","unstructured":"Xu W, Wang J, Li XN, Liang J, Song L, Wu Y, Liu Z, Sun B, Li WG (2023) Neuronal and synaptic adaptations underlying the benefits of deep brain stimulation for Parkinson\u2019s disease. Transl Neurodegener 12:55","journal-title":"Transl Neurodegener"},{"key":"10128_CR237","doi-asserted-by":"publisher","first-page":"1535682","DOI":"10.3389\/fmed.2025.1535682","volume":"12","author":"VK Yadav","year":"2025","unstructured":"Yadav VK, Dhanasekaran S, Choudhary N, Nathiya D, Thakur V, Gupta R, Pramanik S, Kumar P, Gupta N, Patel A (2025) Recent advances in nanotechnology for Parkinson\u2019s disease: diagnosis, treatment, and future perspectives. Front Med (Lausanne) 12:1535682","journal-title":"Front Med (Lausanne)"},{"key":"10128_CR238","doi-asserted-by":"publisher","first-page":"105218","DOI":"10.1016\/j.nbd.2020.105218","volume":"148","author":"J Yang","year":"2021","unstructured":"Yang J, Luo S, Zhang J, Yu T, Fu Z, Zheng Y, Xu X, Liu C, Fan M, Zhang Z (2021) Exosome-mediated delivery of antisense oligonucleotides targeting alpha-synuclein ameliorates the pathology in a mouse model of Parkinson\u2019s disease. Neurobiol Dis 148:105218","journal-title":"Neurobiol Dis"},{"key":"10128_CR239","doi-asserted-by":"publisher","first-page":"87","DOI":"10.4103\/0019-5545.58907","volume":"52","author":"VK Yeragani","year":"2010","unstructured":"Yeragani VK, Tancer M, Chokka P, Baker GB (2010) Arvid Carlsson, and the story of dopamine. Indian J Psychiatry 52:87\u201388","journal-title":"Indian J Psychiatry"},{"key":"10128_CR240","doi-asserted-by":"publisher","first-page":"323","DOI":"10.5483\/BMBRep.2022.55.7.073","volume":"55","author":"H Yoo","year":"2022","unstructured":"Yoo H, Lee J, Kim B, Moon H, Jeong H, Lee K, Song WJ, Hur JK, Oh Y (2022) Role of post-translational modifications on the alpha-synuclein aggregation-related pathogenesis of Parkinson\u2019s disease. BMB Rep 55:323\u2013335","journal-title":"BMB Rep"},{"key":"10128_CR241","volume-title":"Parkinson\u2019s disease: pathogenesis and clinical aspects","author":"I Zahoor","year":"2018","unstructured":"Zahoor I, Shafi A, Haq E (2018) Pharmacological treatment of Parkinson\u2019s disease. In: Stoker TB, Greenland JC (eds) Parkinson\u2019s disease: pathogenesis and clinical aspects. Codon, Brisbane (AU)"},{"key":"10128_CR243","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/ana.10795","volume":"55","author":"JJ Zarranz","year":"2004","unstructured":"Zarranz JJ, Alegre J, Gomez-Esteban JC, Lezcano E, Ros R, Ampuero I, Vidal L, Hoenicka J, Rodriguez O, Atares B, Llorens V, Gomez Tortosa E, del Ser T, Munoz DG, de Yebenes JG (2004) The new mutation, E46K, of alpha-synuclein causes Parkinson and lewy body dementia. Ann Neurol 55:164\u2013173","journal-title":"Ann Neurol"},{"key":"10128_CR245","doi-asserted-by":"publisher","first-page":"e0119928","DOI":"10.1371\/journal.pone.0119928","volume":"10","author":"S Zhang","year":"2015","unstructured":"Zhang S, Xiao Q, Le W (2015) Olfactory dysfunction and neurotransmitter disturbance in olfactory bulb of Transgenic mice expressing human A53T mutant alpha-synuclein. PLoS ONE 10:e0119928","journal-title":"PLoS ONE"},{"key":"10128_CR244","doi-asserted-by":"publisher","first-page":"381","DOI":"10.3389\/fnins.2019.00381","volume":"13","author":"J Zhang","year":"2019","unstructured":"Zhang J, Li X, Li JD (2019) The roles of Post-translational modifications on alpha-Synuclein in the pathogenesis of Parkinson\u2019s diseases. Front Neurosci 13:381","journal-title":"Front Neurosci"},{"key":"10128_CR246","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.nbd.2019.01.004","volume":"125","author":"A Zharikov","year":"2019","unstructured":"Zharikov A, Bai Q, De Miranda BR, Van Laar A, Greenamyre JT, Burton EA (2019) Long-term RNAi knockdown of alpha-synuclein in the adult rat substantia Nigra without neurodegeneration. Neurobiol Dis 125:146\u2013153","journal-title":"Neurobiol Dis"},{"key":"10128_CR247","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.cell.2020.03.024","volume":"181","author":"H Zhou","year":"2020","unstructured":"Zhou H, Su J, Hu X, Zhou C, Li H, Chen Z, Xiao Q, Wang B, Wu W, Sun Y, Zhou Y, Tang C, Liu F, Wang L, Feng C, Liu M, Li S, Zhang Y, Xu H, Yao H, Shi L, Yang H (2020) Glia-to-Neuron conversion by CRISPR-CasRx alleviates symptoms of neurological disease in mice. Cell 181:590\u2013603 e516","journal-title":"Cell"}],"container-title":["Mammalian Genome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00335-025-10128-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00335-025-10128-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00335-025-10128-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T14:50:19Z","timestamp":1748962219000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00335-025-10128-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,28]]},"references-count":246,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["10128"],"URL":"https:\/\/doi.org\/10.1007\/s00335-025-10128-w","relation":{},"ISSN":["0938-8990","1432-1777"],"issn-type":[{"value":"0938-8990","type":"print"},{"value":"1432-1777","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,28]]},"assertion":[{"value":"26 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We have mostly used Google Scholar and PubMed to search for the articles with the following keywords: \u2018olfaction and Parkinson\u2019s Disease\u2019; \u2018Animal models in Parkinson\u2019s Disease\u2019; \u2018\u03b1-synuclein toxicity in Parkinson\u2019s Disease\u2019 and \u2018olfaction and \u03b1-synuclein.\u2019 As we aimed to provide a narrative overview on the topic of Review, we are summarizing the selected and relevant literature.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Review criteria"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}